var title_f1_48_1792="Parulis";
var content_f1_48_1792=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F73999&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F73999&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Parulis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 256px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A carious lower primary molar with two draining fistulas. A fistula in the primary dentition is often called a parulis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Caulfield PW, Griffen AL. Dental caries. An infectious and transmissible disease. Pediatr Clin North Am 2000; 47:1001. Copyright &copy; 2000 WB Saunders.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_48_1792=[""].join("\n");
var outline_f1_48_1792=null;
var title_f1_48_1793="Extending perinephric abscess";
var content_f1_48_1793=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F51469&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F51469&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Extensive perinephric abscess on computed tomography scan",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 369px; height: 277px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Computed tomographic scan of a right perinephric phlegmon with extension toward the flank wall.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Olivier Helenon, MD, Hopital Necker, Paris.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_48_1793=[""].join("\n");
var outline_f1_48_1793=null;
var title_f1_48_1794="Normal pancreas EUS";
var content_f1_48_1794=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F53041&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F53041&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Endoscopic ultrasound image of a normal pancreas",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 333px; height: 307px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Note the uniform gray parenchyma of the body of the pancreas (BP) without lobulations. The main pancreatic duct (PD) is uniform in diameter and measures less than 2 mm. The adjacent structure is the splenic vein (SV).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Michael B Wallace, MD, MPH. SV BP PD",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_48_1794=[""].join("\n");
var outline_f1_48_1794=null;
var title_f1_48_1795="GBM MRI";
var content_f1_48_1795=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F65860&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F65860&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 521px\">",
"   <div class=\"ttl\">",
"    Glioblastoma multiforme",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 501px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Left: Axial T1-weighted MRI showing edematous right temporal lobe with loss of sulci and gray-white demarcation. Right: after gadolinium infusion, a circular 2.5 cm x 2.5 cm area of irregular contrast enhancement in the left temporal lobe (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Harry Greenberg, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_48_1795=[""].join("\n");
var outline_f1_48_1795=null;
var title_f1_48_1796="Meningitis in children";
var content_f1_48_1796=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Meningitis in children (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?1/48/1796/contributors\">",
"       Authors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/48/1796/contributors\" id=\"au4413\">",
"       Sheldon L Kaplan, MD",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/48/1796/contributors\" id=\"au6543\">",
"       Cecilia Di Pentima, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?1/48/1796/contributors\">",
"       Section Editors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/48/1796/contributors\" id=\"se4583\">",
"       Morven S Edwards, MD",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/48/1796/contributors\" id=\"se1864\">",
"       Douglas R Nordli, Jr, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?1/48/1796/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/48/1796/contributors\" id=\"de5754\">",
"       Mary M Torchia, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?1/48/1796?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      MENINGITIS OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Meningitis is the medical term for inflammation of the tissues (meninges) that surround the brain and spinal cord. The inflammation is most commonly caused by a virus or a bacterium, which travels from an infection in another part of the body through the bloodstream to the meninges. The treatment and long-term outlook of meningitis differ considerably based upon the cause.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      MENINGITIS CAUSES",
"     </span>",
"    </p>",
"    <p>",
"     There are two main types of meningitis: viral and bacterial.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3\">",
"     <span class=\"h2\">",
"      Bacterial meningitis",
"     </span>",
"     &nbsp;&mdash;&nbsp;There are many types of bacteria that can cause bacterial meningitis. The most likely type depends upon the child's age, history of vaccinations, and current or past medical problems.",
"    </p>",
"    <p>",
"     Certain factors can increase a child's risk of developing bacterial meningitis, including recent exposure to someone with bacterial meningitis, recent infection (eg, ear or sinus infection), travel to areas where bacterial meningitis is common (eg, sub-Saharan Africa), serious head injury, problems with the immune system, presence of cochlear implants, and certain anatomic abnormalities.",
"    </p>",
"    <p>",
"     Bacterial meningitis is a medical emergency that must be treated quickly to minimize the risk of serious illness or even death. Even when treated appropriately, children who recover from bacterial meningitis sometimes have long-term complications.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Viral meningitis",
"     </span>",
"     &nbsp;&mdash;&nbsp;The most common cause of viral meningitis is a family of viruses called enterovirus. In the United States, enteroviral meningitis is seen more frequently from June to October. Enteroviruses are spread by direct contact with feces during activities such as diaper changing or indirectly through contaminated water, food, and surfaces.",
"    </p>",
"    <p>",
"     Other viruses that cause meningitis can be spread by airborne droplets, direct contact, during birth, or through the bite of an animal (eg, rabies) or insect (eg, mosquito, tick).",
"    </p>",
"    <p>",
"     Viral meningitis is more common than bacterial meningitis in developed countries and is generally less severe. Children with viral meningitis usually recover completely with supportive treatment.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H5\">",
"     <span class=\"h1\">",
"      MENINGITIS SIGNS AND SYMPTOMS",
"     </span>",
"    </p>",
"    <p>",
"     Although bacterial meningitis is usually more severe, the signs and symptoms of bacterial and viral meningitis can be similar, and it is often not possible to know which type of infection is present based upon symptoms alone. The most common symptoms include:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Newborns may develop a fever accompanied by nonspecific symptoms (eg, poor feeding, vomiting, diarrhea, rash). The infant may have a stiff neck or bulging fontanel (soft spot on the skull) and may be irritable, restless, or lethargic.",
"      </li>",
"      <li>",
"       Older children may develop a sudden fever, headache, nausea, vomiting, confusion, stiff neck, and complain that light bothers their eyes.",
"      </li>",
"      <li>",
"       Bacterial meningitis can cause seizures, and decreased level of awareness. Certain types of bacterial meningitis may be associated with petechiae and purpura (red to purplish spots on the skin that do not blanch with pressure).",
"      </li>",
"      <li>",
"       The symptoms of viral meningitis can resemble those of the flu, including fever, muscle aches, runny nose, and cough. One type of viral meningitis causes a slightly red to pink skin rash.",
"      </li>",
"      <li>",
"       In some cases symptoms worsen slowly, over 1 to 2 days, while in other cases the symptoms worsen rapidly over hours.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H6\">",
"     <span class=\"h1\">",
"      MENINGITIS DIAGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     Because bacterial meningitis is a medical emergency that must be treated promptly, it is important to determine the cause of the child's symptoms as quickly as possible. The following tests are generally recommended, and are usually performed in a hospital emergency department:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       A blood culture &ndash; A sample of blood is cultured in the laboratory to determine if there are bacteria present (normally, no bacteria should be present in the blood). The results of the blood culture can also help determine which antibiotic is best. The results of a blood culture are generally not available for 48 to 72 hours.",
"      </li>",
"      <li>",
"       Lumbar puncture &ndash; During a lumbar puncture, also known as a spinal tap, a clinician uses a needle to remove a sample of spinal fluid from the area around the spinal cord in the low back. Several tests are done on the fluid to determine if a bacterial infection is present, and if so, which antibiotic treatment is best.",
"       <br/>",
"       <br/>",
"       The initial results are available within a matter of hours, but the bacterial culture usually takes 48 to 72 hours. If the signs, symptoms, season, or initial spinal fluid results suggest that the child may have viral meningitis, the spinal fluid may be sent for virologic studies, including viral cultures. Viral cultures may take five or more days.",
"      </li>",
"      <li>",
"       Imaging tests &ndash; In some cases, an imaging test such as a CT scan will be recommended before the lumbar puncture. The purpose of this test is to help determine if it is safe to perform the lumbar puncture and to determine if another condition may be contributing to the child's symptoms (eg, bleeding or a mass in the brain).",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H7\">",
"     <span class=\"h1\">",
"      MENINGITIS TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     The treatment for meningitis depends upon whether the meningitis is caused by a virus or a bacterium. However, this distinction may not be clear until the culture results are available (usually 48 to 72 hours after they are obtained). In many cases, children are treated as if they have bacterial meningitis until bacterial meningitis is definitively excluded. The reason for this is that there is a significant risk of serious illness or even death if the child has bacterial meningitis and treatment is delayed for a prolonged period of time.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      Bacterial meningitis",
"     </span>",
"     &nbsp;&mdash;&nbsp;Bacterial meningitis is a life-threatening illness that requires hospitalization and treatment with intravenous antibiotics. The child will be monitored closely for signs of complications. Depending upon the severity of the illness, the child may also need supportive treatments to aid breathing, maintain blood pressure, prevent excessive bleeding, and keep the child hydrated.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Antibiotics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Treatment with antibiotics is usually started immediately after the blood tests and lumbar puncture are performed. Treatment is administered intravenously. Oral antibiotics are not recommended because they cannot get from the blood into the brain and spinal fluid, where the infection is located.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h3\">",
"      Length of treatment",
"     </span>",
"     &nbsp;&mdash;&nbsp;The length of antibiotic treatment depends upon the results of the bacterial cultures.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       If the cultures are negative and the child has improved, antibiotics may be discontinued after 48 to 72 hours.",
"      </li>",
"      <li>",
"       If the cultures are positive, the length of treatment depends upon the bacteria that is identified and whether there are complications. The treatment course may range from several days to several weeks.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      Viral meningitis",
"     </span>",
"     &nbsp;&mdash;&nbsp;In most cases, there is no medication that can eliminate the virus causing viral meningitis. Instead, treatment is supportive, meaning that it is given to support the child while he or she recovers. This generally includes rest, encouraging the child to drink an adequate amount of fluid, and medications to treat fever",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     headache (eg, acetaminophen or ibuprofen). These medications should be dosed according to weight, not age.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H12\">",
"     <span class=\"h1\">",
"      MENINGITIS PROGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     A child's prognosis after an episode of meningitis depends upon the cause (type of bacterium or virus), the severity of the illness, and the age of the child.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h2\">",
"      Bacterial meningitis",
"     </span>",
"     &nbsp;&mdash;&nbsp;A majority of children with bacterial meningitis recover completely with no long-term complications. The child should begin to improve within 24 to 36 hours after starting antibiotics. However, fever may persist for four to six days or longer.",
"    </p>",
"    <p>",
"     However, even with proper treatment, meningitis can damage the brain and cause long-term complications, including deafness, developmental delay or learning disabilities, spastic or paralyzed muscles, and seizures. In developed countries such as the United States, approximately 15 percent of children with bacterial meningitis develop complications. Complications are more common in children who live in developing countries.",
"    </p>",
"    <p>",
"     To determine if a child's hearing was affected by the illness, hearing testing is usually performed around the time of discharge from the hospital. Young children should also be monitored closely for signs of developmental delay (eg, not walking, talking, etc at expected time).",
"    </p>",
"    <p>",
"     Bacterial meningitis is fatal in a small number of cases; between 2001 and 2006, approximately 4 percent of children in the United States with bacterial meningitis died.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h2\">",
"      Viral meningitis",
"     </span>",
"     &nbsp;&mdash;&nbsp;Most children with viral meningitis recover with no long-term complications. Symptoms usually begin to improve within one week, although some children will have fatigue, irritability, decreased concentration, muscle weakness and spasm, and difficulty with coordination for several weeks or more. Death is uncommon in children with viral meningitis.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H15\">",
"     <span class=\"h1\">",
"      MENINGITIS PREVENTION",
"     </span>",
"    </p>",
"    <p>",
"     Several measures can help to reduce the risk of developing bacterial and viral meningitis.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H16\">",
"     <span class=\"h2\">",
"      Vaccines",
"     </span>",
"     &nbsp;&mdash;&nbsp;Several routine childhood vaccines reduce the risk of developing bacterial meningitis, including the pneumococcal, meningococcal, and",
"     <em>",
"      Haemophilus influenzae",
"     </em>",
"     type b (Hib) vaccines. These are discussed in detail separately. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?41/36/42566?source=see_link\">",
"      \"Patient information: Vaccines for infants and children age 0 to 6 years (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?36/18/37156?source=see_link\">",
"      \"Patient information: Vaccines for children age 7 to 18 years (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Vaccines are also available to prevent certain types of viral infections that may cause meningitis or other central nervous system infections, including polio, influenza, varicella, measles, and mumps. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?41/36/42566?source=see_link\">",
"      \"Patient information: Vaccines for infants and children age 0 to 6 years (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?34/12/35013?source=see_link\">",
"      \"Patient information: Influenza symptoms and treatment (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H17\">",
"     <span class=\"h2\">",
"      Preventive antibiotics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Preventive antibiotics are recommended for close contacts of anyone infected with meningococcal infection, even if the contact was previously vaccinated. Close contact is defined as a person who lives with the child or who spent &ge;4 hours with the child for at least 5 of the 7 days before the child developed symptoms.",
"    </p>",
"    <p>",
"     Preventive antibiotics may also be necessary for close contacts of anyone infected with Hib bacterial infection. However, this only applies if the exposed person lives in a household with a child younger than four years of age who did not receive all of the vaccinations against Hib or an individual who has a weakened immune system (even if that person was vaccinated against Hib).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H18\">",
"     <span class=\"h2\">",
"      Infection control",
"     </span>",
"     &nbsp;&mdash;&nbsp;Families of children with meningitis should take care to avoid becoming infected. This includes washing hands after touching the child or changing diapers and before eating or preparing food. Utensils and cups should not be shared, the child's mouth should be covered during a cough, and the child should not be kissed on the mouth. These measures should be continued until the child no longer has symptoms (eg, fever, diarrhea, rash).",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H19\">",
"     <span class=\"h1\">",
"      WHEN TO SEEK HELP",
"     </span>",
"    </p>",
"    <p>",
"     Any parent who suspects that their child could have meningitis should seek medical attention immediately.",
"    </p>",
"    <p>",
"     Signs and symptoms of meningitis can include:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Newborns may develop a fever accompanied by nonspecific symptoms (eg, poor feeding, vomiting, diarrhea, rash). The infant may have a stiff neck or bulging fontanel (soft spot on the skull) and may be irritable, restless, or lethargic.",
"      </li>",
"      <li>",
"       Older children may develop a fever, headache, nausea, vomiting, stiff neck, and complain that the light bothers their eyes. The child may be confused or difficult to awaken.",
"      </li>",
"      <li>",
"       Other signs can include red to purplish spots on the skin (petechiae and purpura), seizures, and a decreased level of awareness.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H20\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your child's healthcare provider is the best source of information for questions and concerns related to your child's medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H2413460258\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5514840\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?3/43/3763?source=see_link\">",
"      Patient information: Meningitis in children (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?16/35/16946?source=see_link\">",
"      Patient information: Aseptic meningitis (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?31/1/31762?source=see_link\">",
"      Patient information: Bacterial meningitis (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/34/28194?source=see_link\">",
"      Patient information: Viral meningitis (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?26/29/27090?source=see_link\">",
"      Patient information: Headaches in children (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?16/47/17138?source=see_link\">",
"      Patient information: Multiple sclerosis in children (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?43/23/44402?source=see_link\">",
"      Patient information: Lumbar puncture (spinal tap) (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5514849\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?41/36/42566?source=see_link\">",
"      Patient information: Vaccines for infants and children age 0 to 6 years (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?36/18/37156?source=see_link\">",
"      Patient information: Vaccines for children age 7 to 18 years (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?34/12/35013?source=see_link\">",
"      Patient information: Influenza symptoms and treatment (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H21\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/47/7928?source=see_link\">",
"      Clinical features and diagnosis of bacterial meningitis in the neonate",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/52/37704?source=see_link\">",
"      Clinical manifestations of meningococcal infection",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/21/4442?source=see_link\">",
"      Dexamethasone and other measures to prevent neurologic complications of bacterial meningitis in children",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28810?source=see_link\">",
"      Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/1/25625?source=see_link\">",
"      Lumbar puncture: Indications, contraindications, technique, and complications in children",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/32/23050?source=see_link\">",
"      Meningococcal vaccines",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/58/31656?source=see_link\">",
"      Neurologic complications of bacterial meningitis in children",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/43/24246?source=see_link\">",
"      Neurologic complications of bacterial meningitis in the neonate",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/42/12970?source=see_link\">",
"      Pneumococcal meningitis in children",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/47/16121?source=see_link\">",
"      Treatment and outcome of bacterial meningitis in the neonate",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38458?source=see_link\">",
"      Treatment and prognosis of acute bacterial meningitis in children older than one month of age",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/21/10586?source=see_link\">",
"      Viral meningitis: Clinical features and diagnosis in children",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/17/22809?source=see_link\">",
"      Viral meningitis: Epidemiology, pathogenesis, and etiology in children",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/51/35640?source=see_link\">",
"      Viral meningitis: Management, prognosis, and prevention in children",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Centers for Disease Control and Prevention (CDC)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;Toll-free: (800) 311-3435",
"     <br/>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.cdc.gov/\">",
"      www.cdc.gov/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"      www.nlm.nih.gov/medlineplus/healthtopics.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Institute of Allergy and Infectious Diseases",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.niaid.nih.gov/\">",
"      www.niaid.nih.gov/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Network for Immunization Information",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.immunizationinfo.org/\">",
"      www.immunizationinfo.org/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Kids Health: The Nemours Foundation",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://kidshealth.org/parent/infections/lung/meningitis.html\">",
"      file://kidshealth.org/parent/infections/lung/meningitis.html",
"     </a>",
"     , available in Spanish)",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?1/48/1796/abstract/1-3\">",
"      1-3",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 26, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?1/48/1796?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1796/abstract/1\">",
"      Logan SA, MacMahon E. Viral meningitis. BMJ 2008; 336:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1796/abstract/2\">",
"      Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004; 39:1267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1796/abstract/3\">",
"      Ch&aacute;vez-Bueno S, McCracken GH Jr. Bacterial meningitis in children. Pediatr Clin North Am 2005; 52:795.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f1_48_1796=[""].join("\n");
var outline_f1_48_1796=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           MENINGITIS OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           MENINGITIS CAUSES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H5\">",
"           MENINGITIS SIGNS AND SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H6\">",
"           MENINGITIS DIAGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H7\">",
"           MENINGITIS TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H12\">",
"           MENINGITIS PROGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H15\">",
"           MENINGITIS PREVENTION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H19\">",
"           WHEN TO SEEK HELP",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H20\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f1_48_1797="Anterior cruciate ligament injury";
var content_f1_48_1797=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Anterior cruciate ligament injury (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?1/48/1797/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/48/1797/contributors\" id=\"au1421\">",
"       Ryan P Friedberg, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?1/48/1797/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/48/1797/contributors\" id=\"se7143\">",
"       Karl B Fields, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?1/48/1797/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/48/1797/contributors\" id=\"de97\">",
"       Jonathan Grayzel, MD, FAAEM",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?1/48/1797?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      ANTERIOR CRUCIATE LIGAMENT INJURY OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     The anterior cruciate ligament (ACL) is an important stabilizing ligament in the knee. It is frequently injured by athletes and trauma victims; in the United States alone, there are between 100,000 and 200,000 ACL tears per year.",
"    </p>",
"    <p>",
"     This topic review will discuss the causes, signs and symptoms, diagnostic tests, and treatment options for ACL injuries.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      WHAT IS THE ANTERIOR CRUCIATE LIAGMENT (ACL)?",
"     </span>",
"    </p>",
"    <p>",
"     The knee joint is held tightly together by four ligaments: the inner and outer fan-shaped hinge ligaments (medial and lateral collateral ligaments) and the crossing (cruciate) ligaments, which sit in the middle of the joint (the anterior and posterior cruciate ligaments) (",
"     <a class=\"graphic graphic_figure graphicRef77293 \" href=\"UTD.htm?10/21/10578\">",
"      figure 1",
"     </a>",
"     ).",
"    </p>",
"    <p>",
"     The collateral ligaments are firmly attached to the far end of the femur (thigh bone) and the near end of the tibia and fibula (lower leg bones). The ligaments hold the two bones together and prevent side to side motion. The anterior cruciate ligament prevents forward and backward motion. You can partially or completely tear the ligament(s).",
"    </p>",
"    <p>",
"     Other structures can be damaged during an acute ACL injury, including:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       The meniscus",
"      </li>",
"      <li>",
"       Joint capsule (the tissue that surrounds the joint)",
"      </li>",
"      <li>",
"       Articular cartilage (cartilage that covers the ends of bones where they meet in a joint)",
"      </li>",
"      <li>",
"       The ends of the femur or tibia",
"      </li>",
"      <li>",
"       Other ligaments (medial collateral ligament (MCL), lateral collateral ligament (LCL), posterior cruciate ligament (PCL)) (",
"       <a class=\"graphic graphic_figure graphicRef51910 \" href=\"UTD.htm?13/3/13361\">",
"        figure 2",
"       </a>",
"       )",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     One common injury is called the athlete's triad, in which the ACL, MCL, and medial meniscus are all torn.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      CAUSES OF ANTERIOR CRUCIATE LIGAMENT INJURY",
"     </span>",
"    </p>",
"    <p>",
"     Non-contact ACL injuries typically occur when a person is running or jumping and then suddenly slows and changes direction (eg, cutting) or pivots in a way that involves rotating or bending the knee sideways. Women appear to be at a higher risk of non-contact ACL injuries than men, although the exact reason for this is not clear [",
"     <a class=\"abstract\" href=\"UTD.htm?1/48/1797/abstract/1\">",
"      1",
"     </a>",
"     ].",
"    </p>",
"    <p>",
"     Contact-related ACL injuries usually occur from a direct blow causing hyperextension or when the knee is forced inwards towards the other leg. This is often seen in American football when a player's foot is planted and an opponent strikes him on the outside or front of that thigh.",
"    </p>",
"    <p>",
"     ACL injuries most commonly occur during the following activities:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Noncontact sports, such as downhill skiing, gymnastics, and tennis",
"      </li>",
"      <li>",
"       Certain contact sports, including rugby, American football, soccer, and basketball",
"      </li>",
"      <li>",
"       Motor vehicle collisions",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H4\">",
"     <span class=\"h1\">",
"      ANTERIOR CRUCIATE LIGAMENT INJURY SYMPTOMS",
"     </span>",
"    </p>",
"    <p>",
"     People who have an ACL injury often complain of feeling a \"pop\" in their knee at the time of injury and have a feeling the knee is unstable or \"giving out.\" Within a few hours of the ACL injury, nearly everyone develops swelling in the knee, caused by bleeding from injured blood vessels; this is called an effusion.",
"    </p>",
"    <p>",
"     After the initial swelling has improved, most people are able to bear weight but feel unsteady on the affected knee. Movements such as squatting, pivoting, and stepping sideways, and activities such as walking down stairs, in which the entire body weight is placed on the affected leg, can cause the feeling of unsteadiness.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H5\">",
"     <span class=\"h1\">",
"      ANTERIOR CRUCIATE LIGAMENT INJURY TESTS",
"     </span>",
"    </p>",
"    <p>",
"     Anyone who experiences a knee injury and subsequently has pain, swelling,",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     feels unsteady while standing should be evaluated by a healthcare provider. The provider will perform a physical examination. An imaging test may be recommended to examine the bones and ligaments.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H6\">",
"     <span class=\"h1\">",
"      ANTERIOR CRUCIATE LIGAMENT INJURY TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     ACL injuries are treated with surgery and post-surgical rehabilitation or a non-surgical rehabilitation program. The decision to have surgery is based upon several factors, including the person's age, level of activity, and the presence of other knee injuries [",
"     <a class=\"abstract\" href=\"UTD.htm?1/48/1797/abstract/2\">",
"      2",
"     </a>",
"     ].",
"    </p>",
"    <p>",
"     A person is likely to choose to have surgery if he or she:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Participates in high-level sports or has a job that requires a strong and stable knee (eg, requires twisting and pivoting)",
"      </li>",
"      <li>",
"       Is unsteady when standing on the injured knee",
"      </li>",
"      <li>",
"       Has multiple injuries",
"      </li>",
"      <li>",
"       Has completed rehabilitation and still has instability in the knee",
"      </li>",
"      <li>",
"       Is willing to complete the rigorous post-surgical rehabilitation program. Most programs require daily strengthening and stretching exercises and one or more weekly visits with a physical therapist for the first three to six months after surgery. (See",
"       <a class=\"local\" href=\"#H12\">",
"        'Post-surgical rehabilitation'",
"       </a>",
"       below.) Failure to follow this program could increase the risk of re-injury, allow scar tissue to develop, and lead to limited movement of the knee.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     A person may decide not to have surgery if he or she:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Has a small partial tear in the ACL that may heal with rest and rehabilitation",
"      </li>",
"      <li>",
"       Does not participate in sports that require pivoting or stopping quickly, especially if the person is older than 55 years",
"      </li>",
"      <li>",
"       Is willing to complete a non-surgical rehabilitation program to strengthen and stabilize the knee (see",
"       <a class=\"local\" href=\"#H11\">",
"        'Non-surgical rehabilitation'",
"       </a>",
"       below)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     If the ACL is not reconstructed, there may be an increased risk of future knee problems, including chronic pain, a decreased level of activity, and injury to other parts of the knee (the meniscus) [",
"     <a class=\"abstract\" href=\"UTD.htm?1/48/1797/abstract/3\">",
"      3",
"     </a>",
"     ].",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Presurgical rehabilitation",
"     </span>",
"     &nbsp;&mdash;&nbsp;Surgery is not usually performed immediately after an ACL injury because this could cause excessive scar tissue (arthrofibrosis) to develop, which would limit knee motion. In most cases, surgery is delayed until the swelling has resolved and the person is able to bend and straighten the knee without difficulty. Using ice packs and elevating the knee above the chest can help to reduce swelling. The time between an ACL injury and surgical reconstruction depends upon how quickly the person recovers.",
"    </p>",
"    <p>",
"     During the time between the injury and the surgery, many surgeons recommend a \"pre-habilitation\" exercise program to help reduce pain and swelling, improve range of motion (the ability to flex and extend the knee), and increase strength in the muscles of the thigh, knee, and hip. Walking, bike riding, and swimming (with light kicks and no breast stroke) can be continued, although other sports should be avoided.",
"    </p>",
"    <p>",
"     An example of a presurgical rehabilitation exercise program is detailed below. (See",
"     <a class=\"local\" href=\"#H11\">",
"      'Non-surgical rehabilitation'",
"     </a>",
"     below.)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      Surgery",
"     </span>",
"     &nbsp;&mdash;&nbsp;After the ACL is torn, it is not possible to repair the ligament. This is due to several factors, including a damaged blood supply to the ligament (blood vessels damaged during injury) and cells inside the synovial fluid (normal fluid in the knee), that prevent healing. Research is underway to determine how to repair the tendon, but the only way to repair the ACL currently is to reconstruct it.",
"    </p>",
"    <p>",
"     Surgical reconstruction of the ACL is usually done in a hospital or surgical center. Most people are given general anesthesia to induce sleep and prevent pain. The surgery itself usually takes less than two hours.",
"    </p>",
"    <p>",
"     To reconstruct the torn ligament, a piece of healthy tendon, called an autograft, is \"harvested\" from another area in the leg. There are several common autograft sites, including the patellar tendon, hamstring tendon, or rarely the quadriceps tendon (",
"     <a class=\"graphic graphic_figure graphicRef58945 \" href=\"UTD.htm?33/56/34689\">",
"      figure 3",
"     </a>",
"     ). Another option is to use a tendon from a deceased donor, called an allograft. No one type of graft has been proven to be better than another. Thus, the type of graft that is used depends upon the surgeon's preference and experience.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       <strong>",
"        Patellar autograft",
"       </strong>",
"       &ndash; When harvesting a patellar autograft, an extra incision is made in the skin to remove a strip of tendon with a piece of bone at each end. The graft site usually heals quickly and regains normal strength. Some people have soreness in this area for several months after surgery, especially if pressure is applied to the area (eg, while kneeling).",
"      </li>",
"      <li>",
"       <strong>",
"        Hamstring autograft",
"       </strong>",
"       &ndash; If using a hamstring autograft, there are no extra incisions needed and the pain at the harvest site is usually less than that seen with a patellar autograft. Hamstring strength usually returns to normal within three to six months.",
"      </li>",
"      <li>",
"       <strong>",
"        Allograft",
"       </strong>",
"       &ndash; Allografts do not require any extra incisions, and there is no risk of pain or weakness at the site of graft harvest.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     The torn ACL is removed and replaced with the graft using a narrow telescope-like device, called an arthroscope. The scope contains a camera and light source, and can be inserted into the knee joint through a small skin incision. Instruments are inserted into other small incisions, allowing the physician to place the graft with precision. After the graft is secured, the knee is wrapped with sterile dressings and an immobilizer is placed around the knee to allow the person to walk more easily with crutches.",
"    </p>",
"    <p>",
"     Most people are able to go home after spending several hours in the recovery room; it is not usually necessary to spend the night. A machine that moves the knee through a range of motions, called a continuous passive motion (CPM) machine, will be used immediately after surgery, and then sent home with the patient. CPM helps to prevent the development of scar tissue. A prescription for pain medications is given to relieve pain at home. Most people visit their surgeon one to two weeks after surgery.",
"    </p>",
"    <p>",
"     During the first few days after surgery, the goal is to control swelling and pain. Elevating the knee above the chest and applying ice to the knee are the best ways to do this. Most people use crutches to assist with walking for the first seven to 10 days after surgery, although most patients are encouraged to begin bearing weight on the affected leg as soon as possible. If more extensive surgery is performed, the surgeon may recommend delaying weight bearing for a longer period. Stretching and strengthening exercises can usually begin within the first few days after surgery.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h3\">",
"      Potential complications",
"     </span>",
"     &nbsp;&mdash;&nbsp;Most people do well after ACL reconstruction and have no major complications. However, complications occasionally occur during surgery or during the rehabilitation period. The most common complications include:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Bleeding into the joint (effusion)",
"      </li>",
"      <li>",
"       Joint infection",
"      </li>",
"      <li>",
"       Blood clot in the deep veins of the leg (deep vein thrombosis)",
"      </li>",
"      <li>",
"       Arthrofibrosis (scar tissue)",
"      </li>",
"      <li>",
"       Loosening of the graft",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H10\">",
"     <span class=\"h1\">",
"      ANTERIOR CRUCIATE LIGAMENT INJURY REHABILITATION",
"     </span>",
"    </p>",
"    <p>",
"     Rehabilitation is a several month long program that is designed to stretch and strengthen the knee after ACL reconstruction or injury. No one program is best for all people, although the following exercises are one example of a program that may be recommended.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      Non-surgical rehabilitation",
"     </span>",
"     &nbsp;&mdash;&nbsp;If surgery is not planned, rehabilitation can help to reduce the risk of further injury. Rehabilitation should begin as soon as swelling and pain begin to improve. Use the stretching and strengthening exercises listed below at least once per day for four to six weeks. These exercises are also recommended as a pre-surgical rehabilitation program.",
"    </p>",
"    <p>",
"     These exercises may cause some discomfort but should not cause significant pain, especially after the exercise session is over. If pain is severe or continues after resting and icing the knee, contact a healthcare provider.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       <strong>",
"        Assisted knee flexion",
"       </strong>",
"       &ndash; Sit on the floor with the legs extended in front of the body. Place the hands behind the injured thigh, bend the knee and pull it towards the chest, keeping the back straight (",
"       <a class=\"graphic graphic_picture graphicRef73144 \" href=\"UTD.htm?41/37/42576\">",
"        picture 1",
"       </a>",
"       ). Hold for five seconds then straighten leg. Repeat 10 to 15 times (one set). Perform a total of three sets.",
"      </li>",
"      <li>",
"       <strong>",
"        Quad sets",
"       </strong>",
"       &ndash; Sit on the floor with the legs extended in front of the body. Place the hands behind the affected knee. Keep the leg straight and contract the quadriceps muscle (just above the knee), which should cause the knee cap to move towards the body (",
"       <a class=\"graphic graphic_picture graphicRef82754 \" href=\"UTD.htm?27/60/28609\">",
"        picture 2",
"       </a>",
"       ). Hold for a count of 10 seconds. Release and rest as needed. Repeat 10 to 15 times (one set). Perform a total of three sets.",
"      </li>",
"      <li>",
"       <strong>",
"        Straight leg raises",
"       </strong>",
"       &ndash; Lie on a bed or the floor. Bend the \"good\" knee and keep the foot on the floor. Keep the injured leg straight. On the injured side, tighten the quadriceps (as above), keep the leg straight, and lift the leg about 18 inches off the floor (",
"       <a class=\"graphic graphic_picture graphicRef78695 \" href=\"UTD.htm?10/31/10736\">",
"        picture 3",
"       </a>",
"       ). Slowly lower the leg back to the bed or floor. Rest as needed. Repeat 10 to 15 times (one set). Perform a total of three sets.",
"      </li>",
"      <li>",
"       <strong>",
"        Calf raises",
"       </strong>",
"       &ndash; Stand behind a chair, holding onto the chair. Slowly rise up and stand on the balls of the feet and toes (",
"       <a class=\"graphic graphic_picture graphicRef55271 \" href=\"UTD.htm?35/38/36448\">",
"        picture 4",
"       </a>",
"       ). Hold for five seconds then slowly roll down onto the entire foot. Rest as needed. Repeat 10 to 15 times (one set). Increase the difficulty of this exercise by rising higher, holding longer, or moving up and down more quickly. Perform a total of three sets.",
"      </li>",
"      <li>",
"       <strong>",
"        Hip extension",
"       </strong>",
"       &ndash; You will need 18 to 24 inches of rubber tubing or an elastic band (eg, Theraband&reg;) to perform these exercises. Secure the tubing around the leg of a heavy piece of furniture or close it in a door. Stand facing the",
"       <span class=\"nowrap\">",
"        furniture/door",
"       </span>",
"       and place the injured leg in the loop of the tubing. You should not have any slack in the tubing. Hold the",
"       <span class=\"nowrap\">",
"        door/furniture",
"       </span>",
"       and extend the injured leg backwards, stretching the tubing as far as possible (",
"       <a class=\"graphic graphic_picture graphicRef79827 \" href=\"UTD.htm?14/29/14801\">",
"        picture 5",
"       </a>",
"       ). Hold for five seconds. Slowly return the leg to the floor. Rest as needed. Repeat 10 to 15 times (one set). Perform a total of three sets.",
"      </li>",
"      <li>",
"       <strong>",
"        Hip abduction",
"       </strong>",
"       &ndash; As above, you will need a piece of rubber tubing or elastic band. Stand with the legs shoulder width apart, with the \"good\" leg closest to the furniture or door. The tubing should loop around the outside of the injured leg. Lift the affected leg to the side, 18 to 24 inches away from the body, stretching the tubing (",
"       <a class=\"graphic graphic_picture graphicRef67013 \" href=\"UTD.htm?32/15/33009\">",
"        picture 6",
"       </a>",
"       ). Hold for five seconds, then slowly release. Rest as needed. Repeat 10 to 15 times (one set). Perform a total of three sets.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Stretching and strengthening should then continue as discussed below. (See",
"     <a class=\"local\" href=\"#H14\">",
"      'Second phase'",
"     </a>",
"     below.)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h2\">",
"      Post-surgical rehabilitation",
"     </span>",
"     &nbsp;&mdash;&nbsp;Most people who have ACL reconstruction will be under the care of a surgeon and physical therapist who will work together to design a rehabilitation program. The following rehabilitation schedule is an example of one that may be recommended.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h3\">",
"      First phase",
"     </span>",
"     &nbsp;&mdash;&nbsp;During the first two weeks after surgery, the goal is to increase range of motion (flexing and extending the knee), maintain strength, minimize the development of scar tissue, and eliminate swelling. Most people begin to walk without crutches by the end of the first week. The knee should be iced and elevated daily to minimize swelling.",
"    </p>",
"    <p>",
"     Exercises during this phase should include those discussed above. (See",
"     <a class=\"local\" href=\"#H7\">",
"      'Presurgical rehabilitation'",
"     </a>",
"     above.)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h3\">",
"      Second phase",
"     </span>",
"     &nbsp;&mdash;&nbsp;Between the third and twelfth weeks after surgery, the goal is to improve range of motion, strength, walking, and balance. Most people are allowed to walk or use an exercise bike for 15 to 20 minutes per day. When possible, walking or running in a pool with a floating belt can be helpful. The following exercises may also be recommended.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       <strong>",
"        Presurgical exercises",
"       </strong>",
"       &ndash; (See",
"       <a class=\"local\" href=\"#H11\">",
"        'Non-surgical rehabilitation'",
"       </a>",
"       above.)",
"      </li>",
"      <li>",
"       <strong>",
"        Quarter squats",
"       </strong>",
"       &ndash; Stand 18 to 24 inches from a wall. Lean back against the wall. Bend both knees slightly (the buttocks should not be lower than the knees), keeping the back straight (",
"       <a class=\"graphic graphic_picture graphicRef64474 \" href=\"UTD.htm?30/40/31361\">",
"        picture 7",
"       </a>",
"       ). Hold for five seconds then slowly stand up straight. Rest as needed. Repeat 10 to 15 times (one set). Perform a total of three sets. To increase the difficulty, bend the knees more deeply, hold for a longer time, and increase the speed.",
"       <br/>",
"       <br/>",
"       Alternately, use an exercise ball to perform squats. Stand up straight, holding the ball between your back and the wall. Slowly bend the knees and lower the back (roll the ball down the wall). Hold for a count of five. Stand up. Repeat 10 to 15 times.",
"      </li>",
"      <li>",
"       <strong>",
"        Bridges",
"       </strong>",
"       &ndash; Lie on your back on the floor. Keep the feet on the floor and bend both knees. Place the hands about 12 inches to the side of the body (on the floor). Lift the buttocks six to eight inches off the floor (",
"       <a class=\"graphic graphic_picture graphicRef68803 \" href=\"UTD.htm?7/35/7729\">",
"        picture 8",
"       </a>",
"       ). Hold for five seconds, then slowly release. Rest as needed. Repeat 10 to 15 times (one set). Perform a total of three sets.",
"       <br/>",
"       <br/>",
"       To increase the difficulty, keep the right foot on the floor and lift the left foot off the floor, keeping the left leg straight. Raise the buttocks using the right foot to support the lower body. Switch sides. Repeat 10 to 15 times (one set). Perform a total of three sets.",
"      </li>",
"      <li>",
"       <strong>",
"        Single-leg calf raises",
"       </strong>",
"       &ndash; Stand behind a chair, holding onto the chair. Lift the \"good\" foot off the floor so that you are standing on the injured leg. Slowly rise up and stand on the ball of the foot and toes (",
"       <a class=\"graphic graphic_picture graphicRef82503 \" href=\"UTD.htm?35/36/36421\">",
"        picture 9",
"       </a>",
"       ). Hold for five seconds then slowly roll down onto the entire foot. Rest as needed. Repeat 10 to 15 times (one set). Increase the difficulty of this exercise by rising higher, holding longer, or moving up and down more quickly. Perform a total of three sets.",
"      </li>",
"      <li>",
"       <strong>",
"        Step ups",
"       </strong>",
"       &ndash; Use a stair climber or steps, step up first with the injured leg. Continue for 10 to 15 minutes per day.",
"      </li>",
"      <li>",
"       <strong>",
"        Balance",
"       </strong>",
"       &ndash; Use a wobble board or balance disk to improve knee strength and balance ability.",
"       <br/>",
"       <br/>",
"       If a wobble board or balance disk is not available, try balancing on the affected leg while lifting the unaffected leg off the ground; do not hold onto any support (",
"       <a class=\"graphic graphic_picture graphicRef56968 \" href=\"UTD.htm?21/26/21920\">",
"        picture 10",
"       </a>",
"       ). Hold this position for a count of five to 10. Rest and repeat 10 to 15 times. To increase the difficulty, raise the unaffected leg into the air.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h3\">",
"      Phase three",
"     </span>",
"     &nbsp;&mdash;&nbsp;During the fourth to sixth months after surgery, the difficulty and intensity of the exercises described above should be continued. In addition, exercises that include jumping and landing can be started.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       <strong>",
"        Lunge",
"       </strong>",
"       &ndash; Stand with the feet together. Step the right foot approximately 36 inches in front of the body. The right knee should be over the right ankle and the left calf should be parallel to the floor (",
"       <a class=\"graphic graphic_picture graphicRef60977 \" href=\"UTD.htm?17/28/17858\">",
"        picture 11",
"       </a>",
"       ). Hold for five seconds. Step the right foot back so that the feet are together. Rest as needed. Repeat with the left leg. Repeat 10 to 15 times (one set). Perform a total of three sets.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Some activities may be resumed at this point, including jogging in a straight line, swimming (kick lightly), and biking on the road. As strength and ability improve, running and other activities can be restarted as well.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H16\">",
"     <span class=\"h2\">",
"      Prognosis",
"     </span>",
"     &nbsp;&mdash;&nbsp;Most people who have surgical reconstruction of the ACL have a good outcome and are usually able to return to all of their previous activities by six months after surgery. Athletes can return to sports once their reconstructed knee demonstrates strength and balance roughly equal to the uninjured knee. This generally occurs within 6 to 12 months, depending upon the sport and the person's dedication to the rehabilitation program.",
"    </p>",
"    <p>",
"     There are no studies that address the risk of reinjury after ACL reconstruction. When ACL reconstruction is done properly, there should be no increased risk of ACL reinjury.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H17\">",
"     <span class=\"h1\">",
"      ANTERIOR CRUCIATE LIGAMENT INJURY PREVENTION",
"     </span>",
"    </p>",
"    <p>",
"     Numerous organizations, including the American Academy of Orthopaedic Surgeons and the American College of Sports Medicine, agree that programs to prevent ACL injury are beneficial for female athletes [",
"     <a class=\"abstract\" href=\"UTD.htm?1/48/1797/abstract/4\">",
"      4",
"     </a>",
"     ]. Many experts also believe that any athlete who is at high-risk for an ACL injury (eg, American football players, skiers) should participate in a prevention program.",
"    </p>",
"    <p>",
"     An analysis of ACL injury prevention programs noted the following:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Programs that incorporated high-intensity jumping exercises reduced injury rates.",
"      </li>",
"      <li>",
"       Programs that analyzed athletes&rsquo; movements and provided direct feedback about proper positioning and movement reduced injury rates.",
"      </li>",
"      <li>",
"       Programs that incorporated strength training reduced injury rates, although strength training alone did not.",
"      </li>",
"      <li>",
"       Balance training alone is unlikely to reduce injury rates, although it may enhance other prevention techniques.",
"      </li>",
"      <li>",
"       Athletes must participate in prevention training at least two times per week for a minimum of six consecutive weeks to accrue benefit.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Prevention programs are usually tailored to a particular sport and should initially be taught and supervised by a knowledgeable athletic trainer, physical therapist, or comparable professional (",
"     <a class=\"external\" href=\"file://www.sportsmed.org/tabs/patienteducation/SportsTipDetails.aspx?DID=380\">",
"      www.sportsmed.org/tabs/patienteducation/SportsTipDetails.aspx?DID=380",
"     </a>",
"     ). Use of external braces or other devices has not been shown to reduce the risk of ACL tears and is not recommended for prevention.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H18\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H181\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H21383292\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?7/12/7362?source=see_link\">",
"      Patient information: Anterior cruciate ligament tear (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?7/36/7747?source=see_link\">",
"      Patient information: Knee pain (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H21383300\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?24/4/24642?source=see_link\">",
"      Patient information: Knee pain (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/13/21717?source=see_link\">",
"      Patient information: Total knee replacement (arthroplasty) (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H20\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/24/32138?source=see_link\">",
"      Anterior cruciate ligament injury",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/29/6618?source=see_link\">",
"      Evaluation of the active adult patient with knee pain",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/48/28422?source=see_link\">",
"      Knee bursitis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/11/3257?source=see_link\">",
"      Medial collateral ligament injury of the knee",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/15/16632?source=see_link\">",
"      Meniscal injury of the knee",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/4/34890?source=see_link\">",
"      Overview of running injuries of the lower extremity",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/42/21157?source=see_link\">",
"      Patella fractures",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/61/43993?source=see_link\">",
"      Patellofemoral pain syndrome",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/52/5957?source=see_link\">",
"      Proximal tibial fractures in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/51/42807?source=see_link\">",
"      Proximal tibial fractures in children",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/ency/article/007208.htm\">",
"      www.nlm.nih.gov/medlineplus/ency/article/007208.htm",
"     </a>",
"     , available in Spanish)",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Academy of Orthopaedic Surgeons",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://orthoinfo.aaos.org/topic.cfm?topic=a00549\">",
"      orthoinfo.aaos.org/topic.cfm?topic=A00549",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Physical Therapy Association",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.apta.org/\">",
"      file://www.apta.org/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?1/48/1797/abstract/1-5\">",
"      1-5",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 9, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?1/48/1797?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1797/abstract/1\">",
"      Prodromos CC, Han Y, Rogowski J, et al. A meta-analysis of the incidence of anterior cruciate ligament tears as a function of gender, sport, and a knee injury-reduction regimen. Arthroscopy 2007; 23:1320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1797/abstract/2\">",
"      Linko E, Harilainen A, Malmivaara A, Seitsalo S. Surgical versus conservative interventions for anterior cruciate ligament ruptures in adults. Cochrane Database Syst Rev 2005; :CD001356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1797/abstract/3\">",
"      Kostogiannis I, Ageberg E, Neuman P, et al. Activity level and subjective knee function 15 years after anterior cruciate ligament injury: a prospective, longitudinal study of nonreconstructed patients. Am J Sports Med 2007; 35:1135.",
"     </a>",
"    </li>",
"    <li>",
"     Female athlete issues for the team physician - A consensus statement. American Academy of Orthopaedic Surgeons 2003. Available on line at: www.aaos.org/about/papers/advistmt/1024.asp (Accessed on 4 February 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1797/abstract/5\">",
"      Benjaminse A, Gokeler A, van der Schans CP. Clinical diagnosis of an anterior cruciate ligament rupture: a meta-analysis. J Orthop Sports Phys Ther 2006; 36:267.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f1_48_1797=[""].join("\n");
var outline_f1_48_1797=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           ANTERIOR CRUCIATE LIGAMENT INJURY OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           WHAT IS THE ANTERIOR CRUCIATE LIAGMENT (ACL)?",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           CAUSES OF ANTERIOR CRUCIATE LIGAMENT INJURY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H4\">",
"           ANTERIOR CRUCIATE LIGAMENT INJURY SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H5\">",
"           ANTERIOR CRUCIATE LIGAMENT INJURY TESTS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H6\">",
"           ANTERIOR CRUCIATE LIGAMENT INJURY TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H10\">",
"           ANTERIOR CRUCIATE LIGAMENT INJURY REHABILITATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H17\">",
"           ANTERIOR CRUCIATE LIGAMENT INJURY PREVENTION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H18\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          FIGURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?10/21/10578\" title=\"figure 1\">",
"           Front view knee PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?13/3/13361\" title=\"figure 2\">",
"           Side view knee PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?33/56/34689\" title=\"figure 3\">",
"           ACL graft sites PI",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          PICTURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/37/42576\" title=\"picture 1\">",
"           Assisted knee flexion PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/60/28609\" title=\"picture 2\">",
"           Quad sets PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?10/31/10736\" title=\"picture 3\">",
"           Straight leg raise PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?35/38/36448\" title=\"picture 4\">",
"           Calf raise PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/29/14801\" title=\"picture 5\">",
"           Hip extension PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?32/15/33009\" title=\"picture 6\">",
"           Hip abduction PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/40/31361\" title=\"picture 7\">",
"           Quarter squat PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?7/35/7729\" title=\"picture 8\">",
"           Bridge",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?35/36/36421\" title=\"picture 9\">",
"           Single leg calf raise PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?21/26/21920\" title=\"picture 10\">",
"           Balance PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/28/17858\" title=\"picture 11\">",
"           Lunge PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f1_48_1798="Corticotropin injection gel: Patient drug information";
var content_f1_48_1798=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Corticotropin injection gel: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/62/2023?source=see_link\">",
"     see \"Corticotropin injection gel: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/33/14871?source=see_link\">",
"     see \"Corticotropin injection gel: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F154674\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      H.P. Acthar&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10022348\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10022350\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691589",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease allergy signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691969",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat MS (multiple sclerosis).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat swelling from autoimmune diseases.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691907",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat infantile spasms.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691910",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat swelling in parts of the body.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10022349\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to corticotropin, pork, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2986740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Brittle bones, very bad heart disease, herpes infection of the eye, poor adrenal function, scleroderma, bad infection, ulcer disease, or very high blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703789",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have surgery and need bed rest.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10022354\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697179",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have been taking this drug for many weeks, talk with your doctor before stopping. You may want to slowly stop this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697613",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before getting any vaccines. Use with this drug may either raise the chance of an infection or make the vaccine not work as well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696653",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid being near anyone with chickenpox or measles.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697204",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor. This drug may raise blood sugar.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698422",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check your blood sugar as you have been told by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697224",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have glaucoma or cataracts, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697265",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood pressure, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697038",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are being treated for any infection, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697345",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have TB (tuberculosis), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697148",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a weak heart, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10022355\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698139",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       High blood sugar. This most often goes back to normal when drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698315",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may have more chance of getting an infection. Wash hands often. Stay away from people with infections, colds, or flu.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698134",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       High blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698392",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698364",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698236",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Mood changes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697937",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in body fat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698390",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Weak bones with long-term use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698255",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Muscle weakness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698341",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin changes (pimples, stretch marks, slow healing, hair growth).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697932",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cataracts or glaucoma with long-term use.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10022357\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698659",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired, weak, or touchy; trembling; having a fast heartbeat, confusion, sweating, or dizziness if you missed a dose or recently stopped this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699062",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699087",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698688",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have been exposed to chickenpox and have not had chickenpox or had a chickenpox vaccine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10022352\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a muscle or into the fatty part of the skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696360",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Your doctor may teach you how to give the shot.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694561",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Before giving the shot, bring it to room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696118",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw away needles in a needle/sharp disposal box and take the box back to your doctor when it is full.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10022353\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10022358\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699391",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a refrigerator. Do not freeze.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10022359\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11239 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.247-9F1D191359-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_48_1798=[""].join("\n");
var outline_f1_48_1798=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F154674\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022348\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022350\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022349\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022354\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022355\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022357\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022352\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022353\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022358\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022359\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?1/62/2023?source=related_link\">",
"      Corticotropin injection gel: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/33/14871?source=related_link\">",
"      Corticotropin injection gel: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_48_1799="Angiotensin converting enzyme inhibitors in acute myocardial infarction: Mechanisms of action";
var content_f1_48_1799=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Angiotensin converting enzyme inhibitors in acute myocardial infarction: Mechanisms of action",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/48/1799/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/48/1799/contributors\">",
"     Guy S Reeder, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/48/1799/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/48/1799/contributors\">",
"     Juan Carlos Kaski, MD, DM, DSc, FRCP, FESC, FACC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/48/1799/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/48/1799/contributors\">",
"     Gordon M Saperia, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/48/1799/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 16, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of modalities may be beneficial in the management of the patient with acute myocardial infarction (MI), including direct angioplasty or fibrinolysis,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , angiotensin converting enzyme (ACE) inhibitors, beta blockers, and nitrates. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/41/44697?source=see_link\">",
"     \"Overview of the acute management of ST elevation myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/20/37193?source=see_link\">",
"     \"Overview of the acute management of unstable angina and non-ST elevation myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A meta-analysis concluded that administration of an ACE inhibitor within 3 to 16 days of infarction can slow the progression of cardiovascular disease and improve the survival rate (",
"    <a class=\"graphic graphic_figure graphicRef58405 \" href=\"UTD.htm?28/62/29677\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1799/abstract/1\">",
"     1",
"    </a>",
"    ]. The mechanisms by which ACE inhibitors improve survival after MI will be reviewed here, beginning with a discussion of infarct expansion. The clinical data supporting the use of ACE inhibitors in this setting are presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/30/26088?source=see_link\">",
"     \"Angiotensin converting enzyme inhibitors and receptor blockers in acute myocardial infarction: Clinical trials\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INFARCT EXPANSION AND REMODELING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Survivors of acute MI have a significant risk of future cardiovascular events. Infarct expansion, due to thinning and stretching of the infarct zone, occurs within hours to days of a transmural MI and is an important prognostic determinant. Significant left ventricular dilation can begin within three hours from the onset of a first myocardial infarction, particularly among patients with anterior wall damage [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1799/abstract/2\">",
"     2",
"    </a>",
"    ]. Patients who develop infarct expansion have a high risk of developing heart failure and sudden death. Pathologic evidence of infarct expansion has been found in up to 60 percent of patients dying from complications of an MI [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1799/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ventricular dilatation itself may be deleterious, independent of the reduction in overall myocardial contractility induced by the infarct. Consistent with this hypothesis is the observation in an animal study that preventing left ventricular dilatation with a restraining mesh placed over the anticipated area of infarction preserved left ventricular geometry and function [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1799/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Following the initial insult in the area of infarction,",
"    <strong>",
"     ventricular remodeling",
"    </strong>",
"    can lead to progressive regional myocardial dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1799/abstract/5-8\">",
"     5-8",
"    </a>",
"    ]. The remodeling process begins with myocyte necrosis and the formation of fibrotic scar; it is followed by elongation of the infarcted segment and then dilatation and hypertrophy of the border zone ventricular myocardium (",
"    <a class=\"graphic graphic_figure graphicRef69944 \" href=\"UTD.htm?38/34/39458\">",
"     figure 2",
"    </a>",
"    ). The extent of microvascular obstruction within the infarcted area during the early healing phase after an infarction is indicative of absent blood flow and predicts left ventricular remodeling and dilatation, independent of infarct size [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1799/abstract/9\">",
"     9",
"    </a>",
"    ]. There is no increase in interstitial fibrosis in the noninfarcted tissue remote from the scar [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1799/abstract/10\">",
"     10",
"    </a>",
"    ]; this tissue retains normal contractility even though it is involved in the remodeling process. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/52/842?source=see_link\">",
"     \"Cardiac remodeling: Clinical assessment and therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     MECHANISM OF ACTION OF ACE INHIBITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Attenuation of remodeling is thought to play an important role in the survival benefit associated with ACE inhibitors after myocardial infarction. These drugs also may have favorable effects on ischemic preconditioning, recurrent myocardial infarction and ischemia, sudden death and fibrinolysis (reduction in plasma plasminogen activator inhibitor-1). (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Reduction in recurrent myocardial infarction and ischemia'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Attenuation of remodeling",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the early stages, ventricular dilatation can be considered beneficial, maintaining stroke volume through the Frank-Starling mechanism. However, over time, the dilating ventricle causes detrimental effects by exerting further demands on the surviving myocardium, a result of increases in wall tension (",
"    <a class=\"graphic graphic_figure graphicRef58408 \" href=\"UTD.htm?40/2/41003\">",
"     figure 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1799/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    ACE inhibitors have favorable effects on certain parameters of remodeling, slowing the rate of left ventricular dilatation over time [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1799/abstract/12-15\">",
"     12-15",
"    </a>",
"    ]; the combination of an ACE inhibitor and an angiotensin II receptor blocker may be even more effective than an ACE inhibitor alone [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1799/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/30/26088?source=see_link\">",
"     \"Angiotensin converting enzyme inhibitors and receptor blockers in acute myocardial infarction: Clinical trials\"",
"    </a>",
"    .) This effect is presumably mediated by inhibition of angiotensin II, which appears to play an important role in the remodeling process. In support of this hypothesis are the observations in humans that ACE is markedly increased at the edge of the infarct scar [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1799/abstract/17\">",
"     17",
"    </a>",
"    ] and that the incidence of LV dilatation after MI is increased in patients with the ACE DD genotype (a genotype associated with increased ACE activity) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1799/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/25/19865?source=see_link&amp;anchor=H14#H14\">",
"     \"Cardiac remodeling: Basic aspects\", section on 'Role of angiotensin II'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The effect of ACE inhibitors on infarct expansion reflects a chronic benefit. There is also experimental evidence that ACE inhibitors have more acute benefits, limiting the following changes that can occur during acute ischemia: myocardial injury, degradation of high-energy phosphate stores, and impairment of endothelium-dependent arteriolar responses [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1799/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. These observations constitute part of the rationale for the early administration of ACE inhibitors (within the first 24 hours) after the diagnosis of acute MI has been made [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1799/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/55/13175?source=see_link\">",
"     \"Angiotensin converting enzyme inhibitors and receptor blockers in acute myocardial infarction: Recommendations for use\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Effect on ischemic preconditioning",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ventricular remodeling after a myocardial infarction may interfere with ischemic preconditioning. This was examined in one animal study that found that the myocardium that was remodeled after an infarction was refractory to ischemic preconditioning; this was due to the interruption of cellular signaling of mitochondrial ATP-dependent potassium channels [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1799/abstract/22\">",
"     22",
"    </a>",
"    ]. The angiotensin II receptor blocker",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/4/31815?source=see_link\">",
"     valsartan",
"    </a>",
"    was beneficial for suppressing remodeling and preserving ischemic preconditioning. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/28/9673?source=see_link\">",
"     \"Definition and pathogenesis of ischemic preconditioning\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Reduction in recurrent myocardial infarction and ischemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;ACE inhibitors appear to reduce the incidence of recurrent myocardial infarction. As an example, the Survival and Ventricular Enlargement (SAVE) Trial of 2231 patients found that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/59/9145?source=see_link\">",
"     captopril",
"    </a>",
"    was associated with a significant reduction in recurrent MI by 25 percent. This benefit was noted in all patient groups, including those who received other adjunctive therapies such as fibrinolysis,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    ,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    beta blockers [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1799/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The reduction in recurrent MI suggests that ACE inhibitor therapy has benefits beyond afterload reduction. How this might occur is not known; ACE inhibitors do not appear to reduce the degree of atherosclerosis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1799/abstract/24\">",
"     24",
"    </a>",
"    ]. The following factors may contribute:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Improvement in the oxygen",
"      <span class=\"nowrap\">",
"       supply/demand",
"      </span>",
"      ratio of the myocardium by reversing angiotensin II-induced vasoconstriction and inotropic activity. Among the clinical benefits that could be explained by this mechanism are increased myocardial blood flow to ischemic regions [",
"      <a class=\"abstract\" href=\"UTD.htm?1/48/1799/abstract/25\">",
"       25",
"      </a>",
"      ] and an improvement in resting left ventricular function and reduced diastolic dysfunction during exercise [",
"      <a class=\"abstract\" href=\"UTD.htm?1/48/1799/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Improvement in endothelial function [",
"      <a class=\"abstract\" href=\"UTD.htm?1/48/1799/abstract/27\">",
"       27",
"      </a>",
"      ]. This is probably related to inhibition of angiotensin II-related vasoconstriction and to diminished breakdown of bradykinin, which enhances endothelial release of nitric oxide&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?1/48/1799/abstract/28\">",
"       28",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/39/23162?source=see_link\">",
"       \"Endothelial dysfunction\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Improvement in the hypercoagulable state after an MI by reducing plasma plasminogen activator inhibitor-1 (PAI-1) [",
"      <a class=\"abstract\" href=\"UTD.htm?1/48/1799/abstract/29-31\">",
"       29-31",
"      </a>",
"      ] and tissue factor levels [",
"      <a class=\"abstract\" href=\"UTD.htm?1/48/1799/abstract/32\">",
"       32",
"      </a>",
"      ] and increasing the release of tissue type plasminogen activator (tPA) by the endothelial cells within the coronary artery. Bradykinin stimulates the release of tPA, an effect that is enhanced by an ACE inhibitor, at least in women [",
"      <a class=\"abstract\" href=\"UTD.htm?1/48/1799/abstract/33,34\">",
"       33,34",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/41/23193?source=see_link\">",
"       \"Fibrinolytic markers and cardiovascular risk\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Inhibition of the activation and accumulation of macrophages and monocytes by diminishing the levels of monocyte chemoattractant protein-1 [",
"      <a class=\"abstract\" href=\"UTD.htm?1/48/1799/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are conflicting data regarding a possible benefit of ACE inhibitor therapy in reducing exercise-induced ischemia. In one trial of 43 patients randomly assigned to either",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/19/8505?source=see_link\">",
"     enalapril",
"    </a>",
"    10 mg twice daily or placebo, the exercise time to 1 mm ST segment depression was significantly increased by enalapril at twelve weeks though not at three weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1799/abstract/35\">",
"     35",
"    </a>",
"    ]. In another trial of 336 patients randomly assigned to either",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/29/24024?source=see_link\">",
"     quinapril",
"    </a>",
"    40 mg daily or placebo, there was no improvement in the exercise time to 1 mm ST segment depression at eight weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1799/abstract/36\">",
"     36",
"    </a>",
"    ]. The placebo group was then crossed over to 80 mg quinapril daily while the 40 mg group continued the same dose; again there was no difference eight weeks later.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Reduction in sudden death",
"    </span>",
"    &nbsp;&mdash;&nbsp;ACE inhibitors reduce overall cardiovascular and sudden-death mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1799/abstract/37\">",
"     37",
"    </a>",
"    ]. There are several mechanisms that might contribute to the reduction in sudden death (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/54/16233?source=see_link\">",
"     \"Pathophysiology and etiology of sudden cardiac arrest\"",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Decrease in sympathetic activity along with an improvement in baroreceptor sensitivity which enhances vagal tone [",
"      <a class=\"abstract\" href=\"UTD.htm?1/48/1799/abstract/38\">",
"       38",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Attenuation of ventricular remodeling and ventricular dilation, which are factors for arrhythmogenesis",
"     </li>",
"     <li>",
"      Decrease in the incidence of recurrent myocardial infarction, which increases electrical instability",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The addition of angiotensin converting enzyme inhibitor (ACE-I) or receptor blocker (ARB) to standard medical therapy (including",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , thienopyridine, beta blocker, and statin) in patients with recent myocardial infarction improves cardiovascular outcomes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/55/13175?source=see_link\">",
"     \"Angiotensin converting enzyme inhibitors and receptor blockers in acute myocardial infarction: Recommendations for use\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/59/7098?source=see_link\">",
"     \"Overview of the non-acute management of ST elevation myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/33/44569?source=see_link\">",
"     \"Overview of the non-acute management of unstable angina and non-ST elevation myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Attenuation of remodeling is thought to play a critically important role in the survival benefit associated with ACE inhibitors after myocardial infarction. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Attenuation of remodeling'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Other possible mechanisms of benefits include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Preservation of ischemic preconditioning (see",
"      <a class=\"local\" href=\"#H5\">",
"       'Effect on ischemic preconditioning'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Reduction in recurrent myocardial infarction and ischemia (see",
"      <a class=\"local\" href=\"#H6\">",
"       'Reduction in recurrent myocardial infarction and ischemia'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Reduction in sudden death (see",
"      <a class=\"local\" href=\"#H7\">",
"       'Reduction in sudden death'",
"      </a>",
"      above)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/1\">",
"      Flather MD, Yusuf S, K&oslash;ber L, et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet 2000; 355:1575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/2\">",
"      Korup E, Dalsgaard D, Nyvad O, et al. Comparison of degrees of left ventricular dilation within three hours and up to six days after onset of first acute myocardial infarction. Am J Cardiol 1997; 80:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/3\">",
"      Hutchins GM, Bulkley BH. Infarct expansion versus extension: two different complications of acute myocardial infarction. Am J Cardiol 1978; 41:1127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/4\">",
"      Kelley ST, Malekan R, Gorman JH 3rd, et al. Restraining infarct expansion preserves left ventricular geometry and function after acute anteroapical infarction. Circulation 1999; 99:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/5\">",
"      Gaudron P, Eilles C, Kugler I, Ertl G. Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors. Circulation 1993; 87:755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/6\">",
"      Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990; 81:1161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/7\">",
"      Pfeffer MA, Pfeffer JM, Lamas GA. Development and prevention of congestive heart failure following myocardial infarction. Circulation 1993; 87:IV120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/8\">",
"      Sutton MG, Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 2000; 101:2981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/9\">",
"      Gerber BL, Rochitte CE, Melin JA, et al. Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction. Circulation 2000; 101:2734.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/10\">",
"      Marijianowski MM, Teeling P, Becker AE. Remodeling after myocardial infarction in humans is not associated with interstitial fibrosis of noninfarcted myocardium. J Am Coll Cardiol 1997; 30:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/11\">",
"      Yousef ZR, Redwood SR, Marber MS. Postinfarction left ventricular remodelling: where are the theories and trials leading us? Heart 2000; 83:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/12\">",
"      Konstam MA, Kronenberg MW, Rousseau MF, et al. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators. Circulation 1993; 88:2277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/13\">",
"      Greenberg B, Quinones MA, Koilpillai C, et al. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy. Circulation 1995; 91:2573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/14\">",
"      Pfeffer MA, Lamas GA, Vaughan DE, et al. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 1988; 319:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/15\">",
"      Pfeffer MA, Greaves SC, Arnold JM, et al. Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trial. Circulation 1997; 95:2643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/16\">",
"      Mankad S, d'Amato TA, Reichek N, et al. Combined angiotensin II receptor antagonism and angiotensin-converting enzyme inhibition further attenuates postinfarction left ventricular remodeling. Circulation 2001; 103:2845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/17\">",
"      Hokimoto S, Yasue H, Fujimoto K, et al. Expression of angiotensin-converting enzyme in remaining viable myocytes of human ventricles after myocardial infarction. Circulation 1996; 94:1513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/18\">",
"      Oosterga M, Voors AA, de Kam PJ, et al. Plasma angiotensin-converting enzyme activity and left ventricular dilation after myocardial infarction. Circulation 1997; 95:2607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/19\">",
"      Li K, Chen X. Protective effects of captopril and enalapril on myocardial ischemia and reperfusion damage of rat. J Mol Cell Cardiol 1987; 19:909.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/20\">",
"      Piana RN, Wang SY, Friedman M, Sellke FW. Angiotensin-converting enzyme inhibition preserves endothelium-dependent coronary microvascular responses during short-term ischemia-reperfusion. Circulation 1996; 93:544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/21\">",
"      Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group. Circulation 1998; 97:2202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/22\">",
"      Miki T, Miura T, Tsuchida A, et al. Cardioprotective mechanism of ischemic preconditioning is impaired by postinfarct ventricular remodeling through angiotensin II type 1 receptor activation. Circulation 2000; 102:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/23\">",
"      Vantrimpont P, Rouleau JL, Wun CC, et al. Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. SAVE Investigators. J Am Coll Cardiol 1997; 29:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/24\">",
"      MacMahon S, Sharpe N, Gamble G, et al. Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease. PART-2 Collaborative Research Group. Prevention of Atherosclerosis with Ramipril. J Am Coll Cardiol 2000; 36:438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/25\">",
"      Schneider CA, Voth E, Moka D, et al. Improvement of myocardial blood flow to ischemic regions by angiotensin-converting enzyme inhibition with quinaprilat IV: a study using [15O] water dobutamine stress positron emission tomography. J Am Coll Cardiol 1999; 34:1005.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/26\">",
"      Willenheimer R, Rydberg E, Oberg L, et al. ACE inhibition with ramipril improves left ventricular function at rest and post exercise in patients with stable ischaemic heart disease and preserved left ventricular systolic function. Eur Heart J 1999; 20:1647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/27\">",
"      Mancini GB, Henry GC, Macaya C, et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation 1996; 94:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/28\">",
"      Prasad A, Husain S, Quyyumi AA. Effect of enalaprilat on nitric oxide activity in coronary artery disease. Am J Cardiol 1999; 84:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/29\">",
"      Vaughan DE, Rouleau JL, Ridker PM, et al. Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. HEART Study Investigators. Circulation 1997; 96:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/30\">",
"      Brown NJ, Abbas A, Byrne D, et al. Comparative effects of estrogen and angiotensin-converting enzyme inhibition on plasminogen activator inhibitor-1 in healthy postmenopausal women. Circulation 2002; 105:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/31\">",
"      Ridker PM, Gaboury CL, Conlin PR, et al. Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function. Circulation 1993; 87:1969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/32\">",
"      Soejima H, Ogawa H, Yasue H, et al. Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction. J Am Coll Cardiol 1999; 34:983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/33\">",
"      Minai K, Matsumoto T, Horie H, et al. Bradykinin stimulates the release of tissue plasminogen activator in human coronary circulation: effects of angiotensin-converting enzyme inhibitors. J Am Coll Cardiol 2001; 37:1565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/34\">",
"      Pretorius M, Rosenbaum D, Vaughan DE, Brown NJ. Angiotensin-converting enzyme inhibition increases human vascular tissue-type plasminogen activator release through endogenous bradykinin. Circulation 2003; 107:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/35\">",
"      van den Heuvel AF, Dunselman PH, Kingma T, et al. Reduction of exercise-induced myocardial ischemia during add-on treatment with the angiotensin-converting enzyme inhibitor enalapril in patients with normal left ventricular function and optimal beta blockade. J Am Coll Cardiol 2001; 37:470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/36\">",
"      Pepine CJ, Rouleau JL, Annis K, et al. Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trial. J Am Coll Cardiol 2003; 42:2049.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/37\">",
"      Domanski MJ, Exner DV, Borkowf CB, et al. Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials. J Am Coll Cardiol 1999; 33:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1799/abstract/38\">",
"      Hikosaka M, Yuasa F, Yuyama R, et al. Effect of angiotensin-converting enzyme inhibitor on cardiopulmonary baroreflex sensitivity in patients with acute myocardial infarction. Am J Cardiol 2000; 86:1241.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 87 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.146-E8BDD971E0-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_48_1799=[""].join("\n");
var outline_f1_48_1799=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H8\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INFARCT EXPANSION AND REMODELING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      MECHANISM OF ACTION OF ACE INHIBITION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Attenuation of remodeling",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Effect on ischemic preconditioning",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Reduction in recurrent myocardial infarction and ischemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Reduction in sudden death",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/87\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/87|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/62/29677\" title=\"figure 1\">",
"      ACE inhibitors improve outcome after MI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?38/34/39458\" title=\"figure 2\">",
"      Cardiac remodeling after anterior MI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?40/2/41003\" title=\"figure 3\">",
"      The law of Laplace",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/30/26088?source=related_link\">",
"      Angiotensin converting enzyme inhibitors and receptor blockers in acute myocardial infarction: Clinical trials",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/55/13175?source=related_link\">",
"      Angiotensin converting enzyme inhibitors and receptor blockers in acute myocardial infarction: Recommendations for use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/25/19865?source=related_link\">",
"      Cardiac remodeling: Basic aspects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/52/842?source=related_link\">",
"      Cardiac remodeling: Clinical assessment and therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/28/9673?source=related_link\">",
"      Definition and pathogenesis of ischemic preconditioning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/39/23162?source=related_link\">",
"      Endothelial dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/41/23193?source=related_link\">",
"      Fibrinolytic markers and cardiovascular risk",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/41/44697?source=related_link\">",
"      Overview of the acute management of ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/20/37193?source=related_link\">",
"      Overview of the acute management of unstable angina and non-ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/59/7098?source=related_link\">",
"      Overview of the non-acute management of ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/33/44569?source=related_link\">",
"      Overview of the non-acute management of unstable angina and non-ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/54/16233?source=related_link\">",
"      Pathophysiology and etiology of sudden cardiac arrest",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_48_1800="Postoperative mediastinitis after cardiac surgery";
var content_f1_48_1800=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Postoperative mediastinitis after cardiac surgery",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/48/1800/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/48/1800/contributors\">",
"     Daniel J Sexton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/48/1800/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/48/1800/contributors\">",
"     John G Bartlett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/48/1800/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/48/1800/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/48/1800/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 28, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prior to the development of modern cardiovascular surgery, most cases of mediastinitis arose from either esophageal perforation or from contiguous spread of odontogenic or retropharyngeal infections. Rarely, primary infections of the mediastinum developed as a result of penetrating trauma or hematogenous spread of infection. However, in modern practice, most cases of mediastinitis are a postoperative complication of cardiovascular or other thoracic surgical procedures.",
"   </p>",
"   <p>",
"    The medical management of sternal wound infection will be reviewed here. The surgical management of sternal wound complications is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/32/14858?source=see_link\">",
"     \"Surgical management of sternal wound complications\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of postoperative mediastinitis is complex and multifactorial. The most important factor is intraoperative wound contamination. Such contamination probably occurs in virtually all patients during the long time interval that large sternotomy wounds are open during cardiac surgery. It is therefore likely that the degree and type of contamination interact with host factors, such as the adequacy of local blood supply, nutrition, and immunologic status, to result in infection in small numbers of patients even if meticulous care is exercised by the surgical team.",
"   </p>",
"   <p>",
"    A number of other preoperative and operative factors occasionally play a role in the pathogenesis of postoperative mediastinitis. These include preoperative skin colonization with potentially pathogenic or highly resistant organisms, disruption of the blood supply to the sternum during surgery, tissue trauma due to electrocautery, and early postoperative wound disruption (eg, from coughing).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Microbiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of patients with postoperative mediastinitis have monomicrobial infections. In two reviews with a total of 350 patients with postoperative mediastinitis, 290 (83 percent) had a single pathogen isolated from their mediastinum or blood [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Virtually any organism can cause mediastinitis. In a prospective review of 316 patients with mediastinitis occurring less than 30 days after sternotomy, the most common microorganisms isolated were methicillin-susceptible Staphylococcus aureus (MSSA) (45 percent), methicillin-resistant S. aureus (MRSA) (16 percent), gram-negative bacilli (17 percent), coagulase-negative staphylococci (13 percent), and streptococci (5 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Postoperative mediastinitis due to MSSA appears to occur more often in the setting of preoperative nasal MSSA colonization, whereas postoperative mediastinitis due to MRSA appears to occur via nosocomial transmission between patients. This was illustrated in a study of 17 cases of mediastinitis observed among 1432 cardiac surgery patients [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/3\">",
"     3",
"    </a>",
"    ]. Among the nine cases due to MSSA, seven had an identical isolate in preoperative nasal and surgical site cultures (as demonstrated by pulsed field gel electrophoresis [PFGE]). Among the eight cases due to MRSA, none had an identical isolate by PFGE, and the same MRSA clone was implicated in all of these cases.",
"   </p>",
"   <p>",
"    Rarely, postoperative mediastinitis is due to unusual organisms such as fungi [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/4,5\">",
"     4,5",
"    </a>",
"    ], Legionella [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/6\">",
"     6",
"    </a>",
"    ], Mycoplasma hominis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/7\">",
"     7",
"    </a>",
"    ], or Nocardia [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/8\">",
"     8",
"    </a>",
"    ] and even Mycobacterium tuberculosis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/40/18055?source=see_link&amp;anchor=H8#H8\">",
"     \"Candida infections of the abdomen and thorax\", section on 'Mediastinitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     INCIDENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of postoperative mediastinitis ranges from 0.4 to 5 percent, with the incidence in most centers being between 1 and 2 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/1,10-12\">",
"     1,10-12",
"    </a>",
"    ]. However, the risk may be considerably higher in certain subsets of patients. As an example, the rates have ranged from 2.5 to 7.5 percent in patients undergoing heart transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/13\">",
"     13",
"    </a>",
"    ], and may be higher if cardiac assist devices are used [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following risk factors for postoperative sternal wound infection have been described [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/11,15-35\">",
"     11,15-35",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    In adults:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Diabetes or perioperative hyperglycemia",
"     </li>",
"     <li>",
"      Obesity",
"     </li>",
"     <li>",
"      Peripheral artery disease",
"     </li>",
"     <li>",
"      Tobacco use",
"     </li>",
"     <li>",
"      Prior cardiac surgery",
"     </li>",
"     <li>",
"      Mobilization of the internal mammary arteries",
"     </li>",
"     <li>",
"      Prolonged surgical procedure (greater than five hours)",
"     </li>",
"     <li>",
"      Return to the operating room within four days postoperatively (eg, control bleeding)",
"     </li>",
"     <li>",
"      Prolonged postoperative intensive care",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There is no consensus as to which risk factors are most important and whether the individual risk factors listed above are independent predictors of an increased risk of postoperative mediastinitis. It is likely that all or many of the above risk factors for infection may be clinically important in selected patients, especially when two or more are present. The risk factors for sternal wound infection in adults are discussed in further detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/32/14858?source=see_link&amp;anchor=H1319298#H1319298\">",
"     \"Surgical management of sternal wound complications\", section on 'Risk factors for sternal wound complications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In children:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Age &lt;1 year [",
"      <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/36\">",
"       36",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Male gender [",
"      <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/12\">",
"       12",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Pediatric risk factors for mediastinitis following cardiac surgery were described in two case control studies. One compared 43 children with postoperative mediastinitis to 184 uninfected controls [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/37\">",
"     37",
"    </a>",
"    ]. Risk of postoperative mediastinitis was significantly increased in patients with a known or suspected genetic syndrome, American Society of Anesthesiologists (ASA) score &gt;3, and presence of intracardiac pacing wires for &gt;3 days (odds ratio 4.5, 3.4, and 15.8 respectively). In the other study involving 72 cases of SSI and 144 controls, independent risk factors for a SSI included age &lt;1 and postoperative exposure to &gt;2 red blood cell transfusions [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/36\">",
"     36",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Furthermore, other traditional risk factors for surgical site infection may also be important [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/10,38\">",
"     10,38",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31290?source=see_link&amp;anchor=H13#H13\">",
"     \"Overview of control measures to prevent surgical site infection\", section on 'Cardiac surgery'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Risk indices",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several risk indices for sternal wound infections following cardiac surgery have been described [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/15,16,27,39,40\">",
"     15,16,27,39,40",
"    </a>",
"    ]. A preoperative scoring system based on a 3-point scale evaluated in a cohort of 4987 patients may be the most useful for predicting the risk of postoperative mediastinitis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/27\">",
"     27",
"    </a>",
"    ]. In this study, points were assigned for diabetes (1 point), a body mass index (BMI) &gt;29 but &lt;35",
"    <span class=\"nowrap\">",
"     kg/m2",
"    </span>",
"    (1 point) and a BMI of 35",
"    <span class=\"nowrap\">",
"     kg/m2",
"    </span>",
"    or greater (2 points). Each point in the scoring system approximately doubled the risk for postoperative surgical-site infection. Subsequent validation of this risk index was noted in a separate study of 269 cases of surgical site infections after coronary artery bypass surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postoperative mediastinitis may follow a fulminant or subacute clinical course. Virtually all patients have fever, tachycardia, chest pain or sternal instability, signs of sternal wound infection, or purulent discharge from the mediastinal area. In one study, for example, sternal wound drainage",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cellulitis were present in 29 of 34 patients (85 percent) with postoperative mediastinitis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/1\">",
"     1",
"    </a>",
"    ]. Other local findings that may be seen include crepitus and edema of the chest wall, and Hamman's sign (a crunching sound that is synchronous with the heart beat and heard by chest auscultation). Although signs of sternal wound infection can precede or follow the recognition of mediastinitis, fever and systemic symptoms appear first in most patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/32/14858?source=see_link&amp;anchor=H104702659#H104702659\">",
"     \"Surgical management of sternal wound complications\", section on 'Wound assessment'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Bacteremia is common in postoperative mediastinitis, occurring in 57 percent of patients with postoperative mediastinitis in one report [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/24\">",
"     24",
"    </a>",
"    ]. In another series, mediastinitis was the underlying cause of bacteremia in 16 of 27 patients with positive blood cultures in the early postoperative period [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/41\">",
"     41",
"    </a>",
"    ]. Bacteremia may precede or follow the recognition of mediastinitis. Because bacteremia may be the first sign of postoperative mediastinitis, the possibility of mediastinitis should be considered carefully during the evaluation of all bacteremic patients following cardiac or thoracic surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Incubation period",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of patients with postoperative mediastinitis show evidence of infection within 14 days of surgery; however, the onset may be delayed for months. In one report, for example, the incubation period ranged from 3 to 417 days after surgery; however, the median time of onset was seven days and began within two weeks in two-thirds of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/24\">",
"     24",
"    </a>",
"    ]. Similar findings were noted in another series in which the onset of infection occurred more than one month after surgery in only 4 of 34 cases [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Laboratory and radiologic features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Almost all patients with postoperative mediastinitis have leukocytosis, but this is a nonspecific finding. Mediastinal widening on chest X-ray, which is a radiologic hallmark of non-postoperative mediastinitis, is rarely seen in patients with mediastinitis following cardiac surgery. Other abnormalities that are rarely seen are air fluid levels in the mediastinum or subcutaneous tissue, and mediastinal air on lateral chest radiographs. However, the last finding is of no utility in patients who are evaluated immediately after surgery.",
"   </p>",
"   <p>",
"    Computed tomography (CT) is better than plain radiography in demonstrating the two hallmark findings of mediastinitis:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Localized mediastinal fluid",
"     </li>",
"     <li>",
"      Pneumomediastinum",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These findings have increasing diagnostic significance with increasing time after surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of postoperative mediastinitis is generally easy in patients who develop their infection within several weeks of surgery. Such patients usually manifest the characteristic clinical pattern of fever, leukocytosis, and sternal instability",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    sternal wound drainage, which may contain bubbles. The diagnosis is virtually assured when these findings occur in the presence of bacteremia or systemic symptoms such as fever, chills,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    signs of sepsis. Typically, such patients are taken immediately to surgery, where the diagnosis can be established definitively by the finding of pus in the mediastinum.",
"   </p>",
"   <p>",
"    The diagnosis may be more difficult to establish in patients with fever and leukocytosis but no signs of sternal wound infection or drainage. In the majority of such patients, sternal wound infection becomes evident within a few days.",
"   </p>",
"   <p>",
"    Another potential difficulty is distinguishing between superficial sternal wound infection and sternal wound infection associated with mediastinitis. As a general rule, patients with mediastinitis have signs of systemic infection such as fever, chills, and, as noted above, bacteremia in more than one-half of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    CT scan",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    subxiphoid aspiration may be useful in patients with systemic symptoms or bacteremia in the absence of sternal wound suppuration and in those with subacute symptoms. The later imaging is performed after surgery, the more likely the findings are to be diagnostically useful. In one study, for example, CT had a sensitivity of 100 percent but a specificity of only 33 percent for postoperative mediastinitis if performed before the postoperative day 14; however, both the specificity and sensitivity were 100 percent when CT scan was performed later [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One group reported on experience using sternal puncture to diagnose postoperative mediastinitis in patients with prior median sternotomies [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/43\">",
"     43",
"    </a>",
"    ]. A 21 gauge needle was placed through the margins of the prior sternotomy site and an aspirate was performed at an approximate depth of one centimeter. If the initial aspirate did not obtain fluid, aspirates were repeated at two other portions of the sternal wound. This approach yielded the same organism as was subsequently found during a later debridement in all 23 mediastinitis patients; cultures and Gram stain of aspirates were negative in 24 of 26 patients without mediastinitis. Although this report suggests that sternal puncture is safe and reliable, the sensitivity, specificity, and safety of this technique require validation by others.",
"   </p>",
"   <p>",
"    Another study examined the utility of blood cultures in diagnosing postoperative mediastinitis in a large number of patients undergoing open heart surgery via a median sternotomy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/44\">",
"     44",
"    </a>",
"    ]. In this cohort of 5500 patients, the detection of S. aureus bacteremia had a likelihood ratio (LR) of 25 for the presence of mediastinitis (95 percent CI, 14.7-44.4). Forty-six of 60 patients (77 percent) who had bacteremia due to S. aureus within 90 days of cardiac surgery developed mediastinitis due to the same organism. Curiously, bacteremia due to other organisms did not have the same prognostic significance: only 15 of 126 patients (12 percent) with non-S. aureus bacteremia developed mediastinitis (LR 1.0; 95 percent CI, 0.6-1.7). Patients with negative blood cultures were significantly less likely to have mediastinitis (LR 0.45; 95 percent CI, 0.35-0.58).",
"   </p>",
"   <p>",
"    Cultures of epicardial pacing wires may be of some utility in patients who present with early-onset postoperative mediastinitis. In one report, such cultures had a sensitivity of 75 percent and a specificity of 83 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/45\">",
"     45",
"    </a>",
"    ]. Although the positive predictive value of a single culture was only 12 percent, the negative predictive value of an individual culture was 99 percent. When S. aureus was isolated from such cultures, the specificity, sensitivity, and positive predictive value were even higher. In my experience, however, these cultures are rarely practical because pacing wires have often been removed by the time mediastinitis manifests or because the diagnosis is obvious from the typical clinical findings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of mediastinitis requires a combination of surgical debridement and antimicrobial therapy. Surgical debridement is the mainstay of therapy for postoperative mediastinitis followed by an immediate closure, or an interval of open wound care followed by delayed primary or flap closure [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/5,10\">",
"     5,10",
"    </a>",
"    ]. The surgical management of sternal wound complications is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/32/14858?source=see_link\">",
"     \"Surgical management of sternal wound complications\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Systemic antimicrobial therapy should be instituted as soon the diagnosis of mediastinitis is established or suspected and after blood cultures have been obtained. Initial empiric therapy should consist of broad coverage against gram-positive cocci and gram-negative bacilli. In hospitals such as ours in which there is a substantial incidence of methicillin-resistant staphylococci, we typically use a regimen consisting of intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    plus a third generation cephalosporin (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/0/17415?source=see_link\">",
"     ceftazidime",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/57/35735?source=see_link\">",
"     cefotaxime",
"    </a>",
"    ), a quinolone (such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    ), or an aminoglycoside. The regimen should be adjusted as soon as the results of cultures of blood and mediastinal or deep sternal wound drainage are available.",
"   </p>",
"   <p>",
"    In general, most favor 2 to 3 weeks of antibiotic therapy following sternal resection and a pectoral flap. If sternal debridement has been performed without resection, or if there is residual rib or sternal bone following surgery that may be a site of residual infection, 4 to 6 weeks of antimicrobial therapy may be required (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/34/4649?source=see_link\">",
"     \"Overview of osteomyelitis in adults\"",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The issue of antibiotic prophylaxis to prevent surgical site infections such as postoperative mediastinitis is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31290?source=see_link&amp;anchor=H13#H13\">",
"     \"Overview of control measures to prevent surgical site infection\", section on 'Cardiac surgery'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/35/10805?source=see_link\">",
"     \"Controversies in control measures to prevent surgical site infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Summarized briefly:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Routine antimicrobial prophylaxis should be administered within 60 minutes before the initial incision. There are conflicting recommendations for repeat dosing during and shortly after the completion of surgery.",
"     </li>",
"     <li>",
"      The usual drugs of choice are intravenous",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/2/4136?source=see_link\">",
"       cefazolin",
"      </a>",
"      (1 g if less than 80 kg and 2 g if more than 80 kg) or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/61/26583?source=see_link\">",
"       cefuroxime",
"      </a>",
"      (1.5 g). Intravenous",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"       vancomycin",
"      </a>",
"      (1 g [10 to 15",
"      <span class=\"nowrap\">",
"       mg/kg])",
"      </span>",
"      is preferred if the patient is previously colonized with MRSA or is allergic to penicillins or cephalosporins, or if surgery is performed in a hospital in which MRSA",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      coagulase-negative staphylococci are a common cause of postoperative infection.",
"      <br/>",
"      <br/>",
"      The antimicrobial regimen may need to be expanded in patients who have cardiac conditions associated with the highest risk of infective endocarditis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=see_link\">",
"       \"Antimicrobial prophylaxis for bacterial endocarditis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Nasopharyngeal and oropharyngeal decontamination with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/36/12870?source=see_link\">",
"       chlorhexidine gluconate",
"      </a>",
"      nasal ointment may reduce deep surgical site infections as well as lower respiratory tract infections in patients undergoing elective cardiac surgery [",
"      <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/46\">",
"       46",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Technical factors that are important for preventing sternal wound infection include appropriate choice of sternal wiring (or suture) technique with proper alignment of the sternal edges and meticulous hemostasis that avoids the excessive use of electrocautery. These issues are discussed further separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/32/14858?source=see_link&amp;anchor=H704058#H704058\">",
"     \"Surgical management of sternal wound complications\", section on 'Sternal closure'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mortality rate in postoperative mediastinitis is between 12 and 50 percent in most contemporary series [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/1,2,10,12,17,47\">",
"     1,2,10,12,17,47",
"    </a>",
"    ]. In one study including 83 patients with mediastinitis, the mortality during the first 90 days after surgery was 12 percent (compared with 6 percent for 6376 patients without mediastinitis) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/17\">",
"     17",
"    </a>",
"    ]. In addition, the interval mortality between one and two years after surgery remained higher in the patients with mediastinitis (8 versus 2 percent). Another study suggested that the risk of death following mediastinitis remains higher than in uninfected controls for up to 10 years (49 versus 71 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/12\">",
"     12",
"    </a>",
"    ]. The majority of deaths in both groups was attributed to cardiac causes, but the proportion of cardiac deaths was higher in patients who had mediastinitis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A prospective study of 316 consecutive cases of postoperative mediastinitis identified patient risk factors for intensive care unit mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/2\">",
"     2",
"    </a>",
"    ]. Independent risk factors present on admission were age greater than 70 years, operation other than coronary artery bypass grafting alone, severity of the underlying medical condition (McCabe class",
"    <span class=\"nowrap\">",
"     2/3),",
"    </span>",
"    APACHE II score, and organ failure. After introducing day three variables into the logistic regression model, the additional independent risk factors for death were mechanical ventilation still required on day three and persistently positive blood cultures.",
"   </p>",
"   <p>",
"    Another study of 183 patients with postoperative mediastinitis found that death occurred in 51 patients (33 percent); median time to death in those who died was 37 days [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/48\">",
"     48",
"    </a>",
"    ]. Independent predictors of death included:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Delay &gt;3 days in sternal closure after debridement (Hazard Ratio [HR] 6.3)",
"     </li>",
"     <li>",
"      Age &gt;65 (HR 2.3)",
"     </li>",
"     <li>",
"      Stay in ICU before sternal debridement (HR 5.6)",
"     </li>",
"     <li>",
"      Serum creatinine &gt;2",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      before debridement (HR 2.5)",
"     </li>",
"     <li>",
"      Infection due to MRSA (HR 2.1)",
"     </li>",
"     <li>",
"      Treatment with antibiotics with in vitro activity against the infecting pathogen within 7 days of debridement was associated with decreased mortality risk (HR 0.4)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Mortality is higher among patients with MRSA than MSSA infection [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/49-51\">",
"     49-51",
"    </a>",
"    ]. This was illustrated in a series of 41 patients with mediastinitis; 15 with MRSA and 26 with MSSA [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/49\">",
"     49",
"    </a>",
"    ]. MRSA mortality rates were higher than MSSA mortality rates at one month (40 versus 15 percent), one year (48 versus 21 percent) and three years (74 versus 21 percent). However, these results should be interpreted with caution since the underlying characteristics of patients with MRSA infections are often substantially different from those of typical patients who acquire infections due to MSSA.",
"   </p>",
"   <p>",
"    Postoperative mediastinitis is also associated with substantial morbidity. The length of stay for affected patients is increased by 38 to 51 days and the total cost of care by two- to threefold compared with control patients [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1800/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15117394\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most contemporary cases of mediastinitis occur as a postoperative complication of thoracic surgical procedures. The majority of infections are caused by a single organism. Although a wide array of bacterial, mycobacterial, and fungal organisms can cause mediastinitis, Staphylococcus aureus is the most commonly isolated pathogen. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3\">",
"       'Microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In adults, risk factors for the development of postoperative mediastinitis include diabetes mellitus, obesity, peripheral arterial disease, tobacco use, a history of prior cardiac surgery, and surgical complications. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The vast majority of patients with postoperative mediastinitis present with fever or other signs of sepsis, chest pain or sternal instability, signs of sternal wound infection, or purulent discharge. Bacteremia is common. The infection typically manifests within two weeks following the surgery, although the onset of symptoms can occasionally occur months later. Hallmark findings on computed tomography are localized mediastinal fluid and a pneumomediastinum. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis is made clinically in a patient presenting with signs and symptoms consistent with postoperative mediastinitis. Computed tomography is more useful in supporting the diagnosis when performed later than two weeks postoperatively. Finding pus in the mediastinum during subsequent surgical debridement can confirm the clinical diagnosis. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The treatment of mediastinitis involves a combination of antimicrobial therapy and surgical debridement with either immediate or delayed closure. An empiric antimicrobial regimen should include broad coverage against both gram-positive cocci (including methicillin-resistant S. aureus, if institutionally prevalent) and gram-negative bacilli and can later be adjusted based on culture and susceptibility data. The duration of therapy generally ranges from two to six weeks and depends on the extent of surgical debridement performed. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Strategies to prevent postoperative mediastinitis include perioperative antibiotics, naso- and oropharyngeal",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/36/12870?source=see_link\">",
"       chlorhexidine",
"      </a>",
"      decontamination, and surgical techniques that ensure alignment of sternal edges and meticulous hemostasis. Mediastinitis is associated with an excess postoperative mortality that can persist for years following the procedure. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Prevention'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H16\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/1\">",
"      Fari&ntilde;as MC, Gald Peralta F, Bernal JM, et al. Suppurative mediastinitis after open-heart surgery: a case-control study covering a seven-year period in Santander, Spain. Clin Infect Dis 1995; 20:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/2\">",
"      Trouillet JL, Vuagnat A, Combes A, et al. Acute poststernotomy mediastinitis managed with debridement and closed-drainage aspiration: factors associated with death in the intensive care unit. J Thorac Cardiovasc Surg 2005; 129:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/3\">",
"      San Juan R, Chaves F, L&oacute;pez Gude MJ, et al. Staphylococcus aureus poststernotomy mediastinitis: description of two distinct acquisition pathways with different potential preventive approaches. J Thorac Cardiovasc Surg 2007; 134:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/4\">",
"      Pertowski CA, Baron RC, Lasker BA, et al. Nosocomial outbreak of Candida albicans sternal wound infections following cardiac surgery traced to a scrub nurse. J Infect Dis 1995; 172:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/5\">",
"      Glower DD, Douglas JM Jr, Gaynor JW, et al. Candida mediastinitis after a cardiac operation. Ann Thorac Surg 1990; 49:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/6\">",
"      Lowry PW, Blankenship RJ, Gridley W, et al. A cluster of legionella sternal-wound infections due to postoperative topical exposure to contaminated tap water. N Engl J Med 1991; 324:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/7\">",
"      Sielaff TD, Everett JE, Shumway SJ, et al. Mycoplasma hominis infections occurring in cardiovascular surgical patients. Ann Thorac Surg 1996; 61:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/8\">",
"      Wenger PN, Brown JM, McNeil MM, Jarvis WR. Nocardia farcinica sternotomy site infections in patients following open heart surgery. J Infect Dis 1998; 178:1539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/9\">",
"      Wang TK, Wong CF, Au WK, et al. Mycobacterium tuberculosis sternal wound infection after open heart surgery: a case report and review of the literature. Diagn Microbiol Infect Dis 2007; 58:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/10\">",
"      El Oakley RM, Wright JE. Postoperative mediastinitis: classification and management. Ann Thorac Surg 1996; 61:1030.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/11\">",
"      Loop FD, Lytle BW, Cosgrove DM, et al. J. Maxwell Chamberlain memorial paper. Sternal wound complications after isolated coronary artery bypass grafting: early and late mortality, morbidity, and cost of care. Ann Thorac Surg 1990; 49:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/12\">",
"      Risnes I, Abdelnoor M, Almdahl SM, Svennevig JL. Mediastinitis after coronary artery bypass grafting risk factors and long-term survival. Ann Thorac Surg 2010; 89:1502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/13\">",
"      Baldwin RT, Radovancevic B, Sweeney MS, et al. Bacterial mediastinitis after heart transplantation. J Heart Lung Transplant 1992; 11:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/14\">",
"      Griffith BP, Kormos RL, Hardesty RL, et al. The artificial heart: infection-related morbidity and its effect on transplantation. Ann Thorac Surg 1988; 45:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/15\">",
"      Kohli M, Yuan L, Escobar M, et al. A risk index for sternal surgical wound infection after cardiovascular surgery. Infect Control Hosp Epidemiol 2003; 24:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/16\">",
"      Russo PL, Spelman DW. A new surgical-site infection risk index using risk factors identified by multivariate analysis for patients undergoing coronary artery bypass graft surgery. Infect Control Hosp Epidemiol 2002; 23:372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/17\">",
"      Milano CA, Kesler K, Archibald N, et al. Mediastinitis after coronary artery bypass graft surgery. Risk factors and long-term survival. Circulation 1995; 92:2245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/18\">",
"      Farrington M, Webster M, Fenn A, Phillips I. Study of cardiothoracic wound infection at St. Thomas' Hospital. Br J Surg 1985; 72:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/19\">",
"      Ottino G, De Paulis R, Pansini S, et al. Major sternal wound infection after open-heart surgery: a multivariate analysis of risk factors in 2,579 consecutive operative procedures. Ann Thorac Surg 1987; 44:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/20\">",
"      Nagachinta T, Stephens M, Reitz B, Polk BF. Risk factors for surgical-wound infection following cardiac surgery. J Infect Dis 1987; 156:967.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/21\">",
"      Koshal A, Hendry P, Raman SV, Keon WJ. Should obese patients not undergo coronary artery surgery? Can J Surg 1985; 28:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/22\">",
"      Gaynes R, Marosok R, Mowry-Hanley J, et al. Mediastinitis following coronary artery bypass surgery: a 3-year review. J Infect Dis 1991; 163:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/23\">",
"      Wouters R, Wellens F, Vanermen H, et al. Sternitis and mediastinitis after coronary artery bypass grafting. Analysis of risk factors. Tex Heart Inst J 1994; 21:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/24\">",
"      Bor DH, Rose RM, Modlin JF, et al. Mediastinitis after cardiovascular surgery. Rev Infect Dis 1983; 5:885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/25\">",
"      Culver DH, Horan TC, Gaynes RP, et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System. Am J Med 1991; 91:152S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/26\">",
"      Lilienfeld DE, Vlahov D, Tenney JH, McLaughlin JS. Obesity and diabetes as risk factors for postoperative wound infections after cardiac surgery. Am J Infect Control 1988; 16:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/27\">",
"      Friedman ND, Bull AL, Russo PL, et al. An alternative scoring system to predict risk for surgical site infection complicating coronary artery bypass graft surgery. Infect Control Hosp Epidemiol 2007; 28:1162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/28\">",
"      Zerr KJ, Furnary AP, Grunkemeier GL, et al. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 1997; 63:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/29\">",
"      Trick WE, Scheckler WE, Tokars JI, et al. Modifiable risk factors associated with deep sternal site infection after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2000; 119:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/30\">",
"      Wilson SJ, Sexton DJ. Elevated preoperative fasting serum glucose levels increase the risk of postoperative mediastinitis in patients undergoing open heart surgery. Infect Control Hosp Epidemiol 2003; 24:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/31\">",
"      Latham R, Lancaster AD, Covington JF, et al. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol 2001; 22:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/32\">",
"      Kouchoukos NT, Wareing TH, Murphy SF, et al. Risks of bilateral internal mammary artery bypass grafting. Ann Thorac Surg 1990; 49:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/33\">",
"      Grossi EA, Esposito R, Harris LJ, et al. Sternal wound infections and use of internal mammary artery grafts. J Thorac Cardiovasc Surg 1991; 102:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/34\">",
"      Seyfer AE, Shriver CD, Miller TR, Graeber GM. Sternal blood flow after median sternotomy and mobilization of the internal mammary arteries. Surgery 1988; 104:899.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/35\">",
"      Dodds Ashley ES, Carroll DN, Engemann JJ, et al. Risk factors for postoperative mediastinitis due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2004; 38:1555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/36\">",
"      Costello JM, Graham DA, Morrow DF, et al. Risk factors for surgical site infection after cardiac surgery in children. Ann Thorac Surg 2010; 89:1833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/37\">",
"      Kagen J, Lautenbach E, Bilker WB, et al. Risk factors for mediastinitis following median sternotomy in children. Pediatr Infect Dis J 2007; 26:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/38\">",
"      Nishida H, Grooters RK, Soltanzadeh H, et al. Discriminate use of electrocautery on the median sternotomy incision. A 0.16% wound infection rate. J Thorac Cardiovasc Surg 1991; 101:488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/39\">",
"      Roy MC, Herwaldt LA, Embrey R, et al. Does the Centers for Disease Control's NNIS system risk index stratify patients undergoing cardiothoracic operations by their risk of surgical-site infection? Infect Control Hosp Epidemiol 2000; 21:186.",
"     </a>",
"    </li>",
"    <li>",
"     Chen L, Anderson D, Kaye K, Sexton DJ. Validating a new predictive instrument for surgical site infections following cardiac bypass surgery. Presented at the Annual IDSA Meeting. San Diego, CA. October 4-7, 2007.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/41\">",
"      Kohman LJ, Coleman MJ, Parker FB Jr. Bacteremia and sternal infection after coronary artery bypass grafting. Ann Thorac Surg 1990; 49:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/42\">",
"      Jolles H, Henry DA, Roberson JP, et al. Mediastinitis following median sternotomy: CT findings. Radiology 1996; 201:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/43\">",
"      Benlolo S, Mat&eacute;o J, Raskine L, et al. Sternal puncture allows an early diagnosis of poststernotomy mediastinitis. J Thorac Cardiovasc Surg 2003; 125:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/44\">",
"      Fowler VG Jr, Kaye KS, Simel DL, et al. Staphylococcus aureus bacteremia after median sternotomy: clinical utility of blood culture results in the identification of postoperative mediastinitis. Circulation 2003; 108:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/45\">",
"      Maroto LC, Aguado JM, Carrascal Y, et al. Role of epicardial pacing wire cultures in the diagnosis of poststernotomy mediastinitis. Clin Infect Dis 1997; 24:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/46\">",
"      Segers P, Speekenbrink RG, Ubbink DT, et al. Prevention of nosocomial infection in cardiac surgery by decontamination of the nasopharynx and oropharynx with chlorhexidine gluconate: a randomized controlled trial. JAMA 2006; 296:2460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/47\">",
"      Braxton JH, Marrin CA, McGrath PD, et al. Mediastinitis and long-term survival after coronary artery bypass graft surgery. Ann Thorac Surg 2000; 70:2004.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/48\">",
"      Karra R, McDermott L, Connelly S, et al. Risk factors for 1-year mortality after postoperative mediastinitis. J Thorac Cardiovasc Surg 2006; 132:537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/49\">",
"      Mekontso-Dessap A, Kirsch M, Brun-Buisson C, Loisance D. Poststernotomy mediastinitis due to Staphylococcus aureus: comparison of methicillin-resistant and methicillin-susceptible cases. Clin Infect Dis 2001; 32:877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/50\">",
"      Engemann JJ, Carmeli Y, Cosgrove SE, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003; 36:592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1800/abstract/51\">",
"      Reddy SL, Grayson AD, Smith G, et al. Methicillin resistant Staphylococcus aureus infections following cardiac surgery: incidence, impact and identifying adverse outcome traits. Eur J Cardiothorac Surg 2007; 32:113.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7014 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-AA4CF5E739-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_48_1800=[""].join("\n");
var outline_f1_48_1800=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15117394\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Microbiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      INCIDENCE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Risk indices",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Incubation period",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Laboratory and radiologic features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15117394\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=related_link\">",
"      Antimicrobial prophylaxis for bacterial endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/40/18055?source=related_link\">",
"      Candida infections of the abdomen and thorax",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/35/10805?source=related_link\">",
"      Controversies in control measures to prevent surgical site infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31290?source=related_link\">",
"      Overview of control measures to prevent surgical site infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/34/4649?source=related_link\">",
"      Overview of osteomyelitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/32/14858?source=related_link\">",
"      Surgical management of sternal wound complications",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_48_1801="Prognosis of community-acquired pneumonia in adults";
var content_f1_48_1801=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Prognosis of community-acquired pneumonia in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/48/1801/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/48/1801/contributors\">",
"     Thomas M File, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/48/1801/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/48/1801/contributors\">",
"     John G Bartlett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/48/1801/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/48/1801/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/48/1801/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 14, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Community-acquired pneumonia (CAP) is defined as an acute infection of the pulmonary parenchyma in a patient who has acquired the infection in the community, as distinguished from hospital-acquired (nosocomial) pneumonia (HAP). A third category of pneumonia, designated healthcare-associated pneumonia (HCAP), is acquired in other healthcare facilities, such as nursing homes, dialysis centers, and outpatient clinics.",
"   </p>",
"   <p>",
"    CAP is a common and potentially serious illness. It is associated with considerable morbidity and mortality, particularly in elderly patients and those with significant comorbidities [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The prognosis of CAP in adults will be reviewed here. A variety of other important issues related to CAP are discussed separately. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The epidemiology and microbiology of CAP. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/49/31514?source=see_link\">",
"       \"Epidemiology, pathogenesis, and microbiology of community-acquired pneumonia in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The diagnostic approach to patients with CAP. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/26/26026?source=see_link\">",
"       \"Diagnostic approach to community-acquired pneumonia in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      How one makes the decision to admit patients with CAP to the hospital. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/36/38473?source=see_link\">",
"       \"Community-acquired pneumonia in adults: Risk stratification and the decision to admit\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Treatment recommendations for CAP in patients treated in the outpatient setting. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/24/24969?source=see_link\">",
"       \"Treatment of community-acquired pneumonia in adults in the outpatient setting\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Treatment recommendations for CAP in patients requiring hospitalization. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/1/40986?source=see_link\">",
"       \"Treatment of community-acquired pneumonia in adults who require hospitalization\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The evidence for efficacy of different antibiotic medications in the empiric treatment of CAP and issues related to drug resistance. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/33/29210?source=see_link\">",
"       \"Antibiotic studies for the treatment of community-acquired pneumonia in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pneumonia in special populations, such as aspiration pneumonia, immunocompromised patients, and hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/18/31017?source=see_link\">",
"       \"Aspiration pneumonia in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/49/21273?source=see_link\">",
"       \"Pulmonary infections in immunocompromised patients\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/7/13433?source=see_link\">",
"       \"Risk factors and prevention of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MORTALITY AND SYMPTOM RESOLUTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mortality associated with community-acquired pneumonia (CAP) in adults was evaluated in a 1996 meta-analysis of 127 studies that reported medical outcomes in over 33,000 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/3\">",
"     3",
"    </a>",
"    ]. The mortality rate ranged from 5.1 percent for combined ambulatory and hospitalized patients (data were not reported for ambulatory patients alone) to 13.6 percent in hospitalized patients to 36.5 percent in patients admitted to the intensive care unit (ICU).",
"   </p>",
"   <p>",
"    Outcomes of patients with CAP were also evaluated in the prospective, multicenter observational Pneumonia PORT (Patient Outcomes Research Team) study of 944 outpatients and 1343 inpatients [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/4\">",
"     4",
"    </a>",
"    ]. The following findings were noted at 30 days after presentation:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among outpatients, there were six deaths (0.6 percent), three of which were related to pneumonia. In addition, 76 percent of patients reported at least one residual symptom (most often fatigue) compared with 45 percent by history in the month before the onset of CAP. However, most had resumed usual activities within seven days. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/24/24969?source=see_link&amp;anchor=H15#H15\">",
"       \"Treatment of community-acquired pneumonia in adults in the outpatient setting\", section on 'Treatment duration and response'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Among inpatients, the mortality rate was 8 percent; 76 percent of which were attributed to pneumonia; most deaths occurred during hospitalization. After hospital discharge, 87 percent had at least one residual symptom at 30 days compared with 65 percent by history in the month before the onset of CAP. Return to normal activities occurred at a median of 24 days for those not employed and 15 days for those employed who returned to work at a median of 22 days. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/1/40986?source=see_link&amp;anchor=H16#H16\">",
"       \"Treatment of community-acquired pneumonia in adults who require hospitalization\", section on 'Clinical response to therapy'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a study of over 2 million cases of CAP between 1987 and 2005 in patients &ge;65 years of age in the United States that were detected through a review of Medicare claims, the age- and sex-adjusted 30-day mortality rate decreased from 13.5 percent to 9.7 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/5\">",
"     5",
"    </a>",
"    ]. After adjustment for comorbidities, there was an even larger reduction in the risk of mortality between 1987 and 2006 (adjusted odds ratio 0.46, 95% CI 0.44-0.47).",
"   </p>",
"   <p>",
"    In contrast, in a subsequent study using data from the United States Nationwide Inpatient Sample (the largest all-payer, publically available national hospital database) between 2003 and 2009, when a primary diagnosis of pneumonia was combined with a primary diagnosis of sepsis or respiratory failure associated with a secondary diagnosis of pneumonia, age- and sex-adjusted inpatient mortality rate increased slightly from 8.3 to 8.8 percent (absolute risk increase 0.5 percent, 95% CI 0.1-0.9%) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/6\">",
"     6",
"    </a>",
"    ]. However, when only the primary diagnosis of pneumonia was assessed, there was a significant decrease in inpatient mortality rate from 5.8 to 4.2 percent (absolute risk reduction 1.6 percent, 95% CI 1.4-1.9%). Notably, over the same time period, there was an increase in the primary diagnosis of sepsis with pneumonia as a secondary diagnosis that counterbalanced the apparent decrease in mortality from pneumonia. These results suggest that a temporal change in diagnostic coding affects longitudinal outcome results in studies that use administrative data [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The above mortality rates represent overall values. Factors at presentation can be used to stratify patients into those at low risk who can usually be treated as outpatients and patients at higher risk who require hospitalization or even direct admission to an ICU. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/36/38473?source=see_link\">",
"     \"Community-acquired pneumonia in adults: Risk stratification and the decision to admit\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H340908692\">",
"    <span class=\"h2\">",
"     In-hospital and postdischarge mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;A retrospective study evaluated 30-day mortality rates using a database of 21,233 Medicare patients with pneumonia aged &ge;65 years who had been discharged from hospitals in the United States in 2000 or 2001 [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/8\">",
"     8",
"    </a>",
"    ]. Overall, 2561 patients (12.1 percent) died within 30 days of admission. Among these, 1343 (52.4 percent) died during the hospital stay and 1218 (47.6 percent) died after discharge. On multivariate analysis, seven factors were associated with death prior to discharge, including systolic blood pressure &lt;90 mmHg, respiratory rate &gt;30",
"    <span class=\"nowrap\">",
"     breaths/minute,",
"    </span>",
"    bacteremia, arterial pH &lt;7.35, blood urea nitrogen &gt;11",
"    <span class=\"nowrap\">",
"     mmol/L,",
"    </span>",
"    arterial P02 &lt;60 mmHg or arterial oxygen saturation &lt;90 percent, and need for mechanical ventilation. Comorbidities were equally associated with death in the hospital and death after discharge.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H371246805\">",
"    <span class=\"h2\">",
"     Long-term outcomes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long-term outcomes for both respiratory status and quality-of-life status were assessed in a study of 102 patients with mild to moderate-severe CAP requiring hospital admission [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/9\">",
"     9",
"    </a>",
"    ]. Well-being generally returned to pre-pneumonia status within six months; persistent respiratory symptoms beyond 28 days were more likely to reflect age or comorbidity than the effect of pneumonia.",
"   </p>",
"   <p>",
"    CAP influences long-term survival of patients who were admitted to the hospital and subsequently discharged; the effect of CAP persists for a long period after discharge. In one study, one of three patients &gt;65 years of age who survived hospitalization for CAP died in the following year [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/10\">",
"     10",
"    </a>",
"    ]. In a study of Veterans Administration patients with a mean age of 69.9 years, those who were discharged from the hospital after treatment for CAP had a significantly shorter duration of survival compared with patients discharged for non-pneumonia diagnoses; among patients with CAP, there was a 50 percent mortality rate at 34 months compared with 84 months among patients without CAP [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/11\">",
"     11",
"    </a>",
"    ].",
"    <br/>",
"    <br/>",
"    In a population-based cohort study of 271 CAP patients requiring ICU admission, the 30-day mortality was 11 percent, but the one-year mortality one was 27 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/12\">",
"     12",
"    </a>",
"    ]. Dependent functional status correlated strongly with both short- and long-term mortality.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Impact of guidelines",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of studies have evaluated the impact of guidelines on the outcome of CAP, although none were designed to compare specific antibiotic regimens in different guidelines [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/13-25\">",
"     13-25",
"    </a>",
"    ]. Most found a benefit to guideline-directed care, although the types of benefit (requirement of admission, duration of hospitalization, mortality, and cost) varied among the studies. All of the studies were performed before the availability of the 2007 Infectious Diseases Society of",
"    <span class=\"nowrap\">",
"     America/American",
"    </span>",
"    Thoracic Society",
"    <span class=\"nowrap\">",
"     (IDSA/ATS)",
"    </span>",
"    consensus guidelines on the management of CAP in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Perhaps the best data come from a multicenter controlled trial using cluster randomization in 1743 patients with CAP who presented to the emergency department in 19 hospitals; the trial compared conventional care with the use of a critical pathway algorithm for hospitalization and treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/13\">",
"     13",
"    </a>",
"    ]. The care pathway included therapy with intravenous and oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33504?source=see_link\">",
"     levofloxacin",
"    </a>",
"    ; in comparison, levofloxacin was not available to physicians in the conventional treatment hospitals.",
"   </p>",
"   <p>",
"    Patients treated according to the algorithm had significant reductions in the number of bed days per patient admitted (4.4 versus 6.1 days) and in the proportion of low-risk patients who were admitted (31 versus 49 percent). Although inpatients at critical pathway hospitals had more severe disease, they required significantly fewer days of intravenous therapy and were more likely to be treated with a single class of antibiotic. These reductions in the use of hospital resources were not associated with any adverse clinical effects, as complications, readmission, mortality, and quality of life were not different between the two groups.",
"   </p>",
"   <p>",
"    An important limitation to observational data in other studies [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/14-23\">",
"     14-23",
"    </a>",
"    ] is that guideline adherence could represent a surrogate marker for other aspects of clinical care rather than being directly responsible for the improved outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/23\">",
"     23",
"    </a>",
"    ]. Nevertheless, the available data support a probable benefit from guideline adherence.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PREDICTORS OF MORTALITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several groups in the United States and Britain have explored factors that predict mortality in hospitalized patients with community-acquired pneumonia (CAP) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/3,26-32\">",
"     3,26-32",
"    </a>",
"    ]. The CURB-65 score and the Pneumonia Severity Index are the most commonly used scoring systems for predicting mortality.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     CURB-65 score",
"    </span>",
"    &nbsp;&mdash;&nbsp;The British Thoracic Society found a 21-fold increase in mortality in patients who had two or more of the following findings [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/27\">",
"     27",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Blood urea nitrogen greater than 20",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (7",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"     </li>",
"     <li>",
"      Diastolic blood pressure less than 60 mmHg",
"     </li>",
"     <li>",
"      Respiratory rate above 30 per minute",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The predictive value of these findings was validated in 245 patients hospitalized for CAP in the United States, 20 of whom (8.2 percent) died [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/28\">",
"     28",
"    </a>",
"    ]. The presence of all three variables predicted a nine-fold greater risk for death with 70 percent sensitivity and 84 percent specificity.",
"   </p>",
"   <p>",
"    These three findings plus confusion (based upon a specific mental test or new disorientation to person, place, or time) and age greater than 65 years constitute the five factors at presentation that make up the CURB-65 score, which is a prediction rule for prognosis used to determine whether a patient should be admitted to the hospital (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?40/62/41952?source=see_link\">",
"     calculator 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/36/38473?source=see_link&amp;anchor=H10#H10\">",
"     \"Community-acquired pneumonia in adults: Risk stratification and the decision to admit\", section on 'CURB-65 score'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Among the 718 patients (mean age 64) in the derivation cohort of CURB-65, 30-day mortality was 0.7, 2.1, 9.2, 14.5, and 40 percent for 0, 1, 2, 3, or 4 factors, respectively; only a small number of patients had five factors [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/33\">",
"     33",
"    </a>",
"    ]. These findings were validated in a subsequent cohort of 3181 patients: 30-day mortality was 0.6, 3.0, 6.1, and 14.3 percent for 0, 1, 2, or 3 or more factors, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The authors of the original CURB-65 report suggested that patients with a CURB-65 score of 0 to 1, who comprised 45 percent of the original cohort and 61 percent of the later cohort, were at low risk and could probably be treated as outpatients, those with a score of 2 should be admitted to the hospital, and those with a score of 3 or more should be assessed for care in the intensive care unit (ICU), particularly if the score was 4 or 5 [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Pneumonia severity index",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Pneumonia Severity Index (PSI) was derived and validated as part of the Pneumonia Patient Outcomes Research Team (PORT) prospective cohort study for the purpose of identifying patients with CAP at low risk for mortality in order to aid with the decision of which patients require hospital admission. Points are assigned based upon gender, age, nursing home residence, comorbidities, physical examination findings, and laboratory and radiographic findings. It is widely used for predicting mortality (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?43/42/44705?source=see_link\">",
"     calculator 2",
"    </a>",
"    )(",
"    <a class=\"graphic graphic_table graphicRef59537 \" href=\"UTD.htm?13/7/13435\">",
"     table 1",
"    </a>",
"    ). The PSI is described in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/36/38473?source=see_link&amp;anchor=H3#H3\">",
"     \"Community-acquired pneumonia in adults: Risk stratification and the decision to admit\", section on 'Pneumonia Severity Index'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17910454\">",
"    <span class=\"h2\">",
"     IDSA/ATS minor criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;The 2007 Infectious Diseases Society of",
"    <span class=\"nowrap\">",
"     America/American",
"    </span>",
"    Thoracic Society",
"    <span class=\"nowrap\">",
"     (IDSA/ATS)",
"    </span>",
"    guidelines for the management of CAP identified two major criteria for direct admission to an intensive care unit (ICU): septic shock requiring vasopressor support and requirement for mechanical ventilation [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/2\">",
"     2",
"    </a>",
"    ]. The presence of either criterion requires ICU care. The guidelines also noted that the need for ICU care is suggested by the presence of at least three minor criteria: respiratory rate &ge;30",
"    <span class=\"nowrap\">",
"     breaths/minute,",
"    </span>",
"    <span class=\"nowrap\">",
"     PaO2/FiO2",
"    </span>",
"    ratio &le;250, multilobar infiltrates, confusion, blood urea nitrogen &ge;20",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (blood urea 7",
"    <span class=\"nowrap\">",
"     mmol/L),",
"    </span>",
"    leukopenia, thrombocytopenia, hypothermia, or hypotension requiring fluid support. In a validation study of patients who did not have the major criteria or a contraindication to ICU admission, the minor criteria were equivalent to the PSI for predicting 30-day mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The performance of the minor criteria for predicting the need for ICU admission is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/36/38473?source=see_link&amp;anchor=H15#H15\">",
"     \"Community-acquired pneumonia in adults: Risk stratification and the decision to admit\", section on 'Admission to intensive care'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Additional factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Additional factors that have been associated with increased mortality (many of which are included in the PSI described above) include more severe infection (as manifested by hypothermia, systolic hypotension, bacteremia, multilobar pneumonia,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    altered mental status), comorbid conditions (diabetes, malignancy, neurologic disease, leukopenia), increasing age, abnormal platelet count (ie, &lt;100,000 or",
"    <span class=\"nowrap\">",
"     &gt;400,000/L),",
"    </span>",
"    and failure of initial therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/3,36-39\">",
"     3,36-39",
"    </a>",
"    ]. As an example of the impact of increased age, in a study that included 1349 patients &ge;65 years of age, the 30-day mortality rate was 5, 11, and 24 percent in patients 65 to 74 years, 75 to 84 years and &ge;85 years, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Among severely ill patients, late ICU admission (day 2 or later) was associated with higher 30-day mortality than ICU admission within 24 hours of presentation (47 versus 23 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Among non-diabetics with CAP, an elevated serum glucose concentration at hospital admission was a predictor of death at 28 and 90 days [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/41\">",
"     41",
"    </a>",
"    ]. Compared with patients with CAP who had a normal serum glucose on admission, those with mild hyperglycemia (serum glucose 6 to 11",
"    <span class=\"nowrap\">",
"     mmol/L",
"    </span>",
"    [108 to 198",
"    <span class=\"nowrap\">",
"     mg/dL])",
"    </span>",
"    had a significantly increased risk of death at 90 days (hazard ratio [HR] 1.56, 95% CI 1.22-2.01). The risk was even higher among patients with a serum glucose concentration &ge;14",
"    <span class=\"nowrap\">",
"     mmol/L",
"    </span>",
"    (252",
"    <span class=\"nowrap\">",
"     mg/dL;",
"    </span>",
"    HR 2.37, 95% CI 1.62-3.46). Patients with pre-existing diabetes had a significantly increased risk of mortality compared with non-diabetics, but this outcome was not significantly affected by serum glucose concentration on admission.",
"   </p>",
"   <p>",
"    In one observational study, low vitamin D concentration (&lt;50",
"    <span class=\"nowrap\">",
"     nmol/L)",
"    </span>",
"    was an independent predictor of 30-day mortality in patients with CAP [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/42\">",
"     42",
"    </a>",
"    ]. However, it is not known whether vitamin D replacement improves outcomes in patients with CAP. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/29/31193?source=see_link&amp;anchor=H651669#H651669\">",
"     \"Vitamin D and extraskeletal health\", section on 'Immune system'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The possible influence of statins on the outcome of CAP is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/63/10230?source=see_link&amp;anchor=H5#H5\">",
"     \"Statins: Possible noncardiovascular benefits\", section on 'Sepsis and infections'",
"    </a>",
"    .)",
"    <br/>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     ICU patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;A scoring system based upon PIRO (Predisposition, Insult, Response, and Organ dysfunction) was developed to predict mortality among patients with severe CAP admitted to the ICU and was compared with the APACHE-II score and the ICU admission criteria recommended by the",
"    <span class=\"nowrap\">",
"     IDSA/ATS",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/43\">",
"     43",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/56/27527?source=see_link\">",
"     \"Predictive scoring systems in the intensive care unit\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/36/38473?source=see_link&amp;anchor=H15#H15\">",
"     \"Community-acquired pneumonia in adults: Risk stratification and the decision to admit\", section on 'Admission to intensive care'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The PIRO score was calculated in 529 patients within 24 hours of ICU admission by giving one point when each of the following variables was present, with a maximum achievable score of 8: comorbidities (chronic obstructive pulmonary disease, immunocompromise), age &gt;70 years, multilobar opacities on chest radiograph, shock, severe hypoxemia, acute renal failure, bacteremia, and acute respiratory distress syndrome. The mean PIRO score was significantly higher in nonsurvivors than survivors (4.6 versus 2.3). Mortality by 28 days increased with the PIRO score as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Low (0 to 2 points) &mdash; 3.6 percent",
"     </li>",
"     <li>",
"      Moderate (3 points) &mdash; 13 percent",
"     </li>",
"     <li>",
"      High (4 points) &mdash; 43 percent",
"     </li>",
"     <li>",
"      Very high (5 to 8 points) &mdash; 76 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The PIRO score performed better than the APACHE-II score and",
"    <span class=\"nowrap\">",
"     ATS/IDSA",
"    </span>",
"    criteria using the area under the receiver-operating characteristic curve. However, validation of the PIRO score is required in other populations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Etiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mortality rates also vary with the cause of pneumonia [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/3,36\">",
"     3,36",
"    </a>",
"    ]. In the meta-analysis described above, the highest mortality rates were seen with gram-negative organisms (Pseudomonas aeruginosa, Klebsiella, Escherichia coli; 41 percent) and Staphylococcus aureus (32 percent), and the lowest mortality rate was with Mycoplasma pneumoniae (1.4 percent). Intermediate mortality rates were seen with Streptococcus pneumoniae and Chlamydophila pneumoniae (12 to 15 percent) and influenza A (9 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/3\">",
"     3",
"    </a>",
"    ]. However, since the total number of cases of CAP due to Pseudomonas and Enterobacteriacae is low compared with the number of cases due to Streptococcus pneumoniae, the majority of deaths due to a defined etiology are due to S. pneumoniae.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     The nonresponding patient",
"    </span>",
"    &nbsp;&mdash;&nbsp;It has been estimated that 6 to 15 percent of hospitalized patients with CAP do not respond to initial antibiotic therapy within 72 hours and the failure rate may be as high as 40 percent in patients initially admitted to an ICU [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/2,38,44\">",
"     2,38,44",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/1/40986?source=see_link&amp;anchor=H22#H22\">",
"     \"Treatment of community-acquired pneumonia in adults who require hospitalization\", section on 'The nonresponding patient'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/24/23945?source=see_link\">",
"     \"Nonresolving pneumonia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Mortality rates are substantially higher in nonresponders. This was illustrated in a review of 1424 hospitalized patients with CAP in which treatment failure occurred in 215 (15 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/38\">",
"     38",
"    </a>",
"    ]. The nonresponders had a mortality rate of 25 percent compared with 2 percent in responders. After adjustment for risk class, failure to respond to empiric antibiotic therapy was associated with an 11-fold increase in mortality. A similar mortality difference (27 versus 4 percent in responders) was noted in another series of 1383 nonimmunocompromised hospitalized patients with CAP [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One cause of treatment nonresponse is the use of discordant therapy, which refers to treatment of an infection with an antimicrobial agent to which the causative organism has demonstrated in vitro resistance, particularly drug-resistant S. pneumoniae. The available data suggest that the impact of discordant therapy varies with antibiotic class and possibly with specific agents within a class. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/33/29210?source=see_link&amp;anchor=H18#H18\">",
"     \"Antibiotic studies for the treatment of community-acquired pneumonia in adults\", section on 'Outcomes with discordant drug therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Vaccination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prior pneumococcal and influenza vaccination appear to improve outcomes in patients with CAP.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Pneumococcus",
"    </span>",
"    &nbsp;&mdash;&nbsp;The potential efficacy of pneumococcal vaccination was illustrated in a prospective, multicenter, population-based cohort study of 3415 adults hospitalized with CAP in which the primary outcome was the composite of in-hospital mortality or ICU admission [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/45\">",
"     45",
"    </a>",
"    ]. Among these patients, 22 percent had previously been vaccinated with the polysaccharide pneumococcal vaccine (PPV). PPV was associated with a significant reduction in the primary outcome (10 versus 21 percent, propensity-adjusted odds of death or ICU admission 0.62, 95% CI 0.42-0.92). Virtually all of the benefit was due to a lower rate of ICU admission. Among over 2400 patients eligible for PPV at hospital discharge, only 9 percent were vaccinated.",
"   </p>",
"   <p>",
"    Benefit was also noted in a retrospective analysis of 63,000 adults hospitalized with CAP, 12 percent of whom had a record of prior pneumococcal vaccination [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/46\">",
"     46",
"    </a>",
"    ]. The following significant benefits were noted in the vaccination group compared with those who had not received the pneumococcal vaccine:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A lower rate of all-cause mortality during hospitalization (adjusted odds ratio [OR] 0.50; 95% CI 0.43-0.59)",
"     </li>",
"     <li>",
"      A lower rate of respiratory failure (adjusted OR 0.67; CI 0.59-0.76)",
"     </li>",
"     <li>",
"      A shorter median length of stay (4.5 versus 6.5 days)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Two additional studies demonstrated the efficacy of PPV in older patients [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. The benefit of PPV was demonstrated in a population-based case-control study of persons 60 years and older (mean age 73) from Spain [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/47\">",
"     47",
"    </a>",
"    ]. The study assessed 88 case patients with invasive pneumococcal disease and 176 matched controls. A lower rate of prior PPV was found in the case patients than the controls (39 versus 59 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a double-blind randomized controlled trial of 1006 nursing home patients (mean age 85 years) in Japan, all-cause pneumonia and pneumococcal pneumonia were significantly more frequent in the placebo group than in the PPV group (91 versus 55 cases per 1000 person-years and 32 versus 12 cases per 1000 person-years, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/48\">",
"     48",
"    </a>",
"    ]. Death from pneumococcal pneumonia was significantly higher in the placebo group than in the PPV group (35 versus 0 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Influenza",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data are also available regarding the efficacy of influenza vaccination in preventing CAP. A cohort study evaluated the efficacy of influenza vaccination in 286,000 individuals over age 65 who were studied during the 1998-1999 and 1999-2000 influenza seasons [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/49\">",
"     49",
"    </a>",
"    ]. The rate of pneumonia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    influenza was reduced by approximately 30 percent. In addition, the rate of all-cause mortality and the rates of cardiac or cerebrovascular diseases were also reduced, the latter two most likely as a result of a reduction of the inflammatory response associated with influenza infection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/8/37002?source=see_link\">",
"     \"Seasonal influenza vaccination in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Prior influenza vaccination appears to decrease mortality in elderly patients who are hospitalized for pneumonia. The magnitude of this effect was illustrated in a retrospective review of the medical records of 12,566 randomly selected Medicare beneficiaries who were hospitalized for pneumonia [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/50\">",
"     50",
"    </a>",
"    ]. Patients with a history of prior vaccination compared with those with unknown vaccination status had significantly lower rates of mortality (hazard ratio 0.65) and readmission (hazard ratio 0.92).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     ASSOCIATION WITH ACUTE CARDIAC EVENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Community-acquired pneumonia (CAP) has been associated with acute cardiac events that may result from cardiac stress, hypoxemia, and inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/51-53\">",
"     51-53",
"    </a>",
"    ]. The association between pneumococcal pneumonia and acute cardiac events was addressed in a review of 170 patients admitted to a Veterans Affairs Medical Center between 2001 and 2005 [",
"    <a class=\"abstract\" href=\"UTD.htm?1/48/1801/abstract/51\">",
"     51",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Thirty-three (19 percent) had at least one acute cardiac event at the time of hospital admission. The events included myocardial infarction in twelve, new onset atrial fibrillation or ventricular tachycardia in eight, and new onset or worsening heart failure, which occurred with or without myocardial infarction or arrhythmia, in thirteen. Most of the affected patients were over age 70 and ten (30 percent) had no prior history of cardiac disease.",
"     </li>",
"     <li>",
"      The coexistence of pulmonary and cardiac disease was often overlooked by admitting physicians.",
"     </li>",
"     <li>",
"      The patients with acute cardiac events had a significantly higher mortality rate than those with pneumonia alone.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?12/29/12754?source=see_link\">",
"       \"Patient information: Community-acquired pneumonia in adults (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?29/38/30308?source=see_link\">",
"       \"Patient information: Pneumonia in adults (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The mortality rate associated with community-acquired pneumonia (CAP) is very low in most ambulatory patients, and higher in patients requiring hospitalization, being as high as 37 percent in patients admitted to the intensive care unit (ICU). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Mortality and symptom resolution'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Adherence to guideline recommendations has been associated with reductions in the proportion of low-risk patients admitted to the hospital and, for those admitted, the duration of hospitalization. Some observational studies have also noted substantial reductions in mortality, but guideline adherence could represent a surrogate marker for other aspects of clinical care. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Impact of guidelines'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A number of risk factors for mortality have been identified. Having two or three of the following variables have been associated with high risk in several studies: blood urea nitrogen greater than 20",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (7",
"      <span class=\"nowrap\">",
"       mmol/L),",
"      </span>",
"      diastolic blood pressure less than 60 mmHg,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      respiratory rate above 30 per minute. These three variables plus confusion and age greater than 65 years constitute the CURB-65 score; patients with 0 or 1 of these factors are at low risk and can usually be treated as outpatients. Underlying comorbidity and the cause of pneumonia also affect the mortality risk. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'CURB-65 score'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      It has been estimated that 6 to 15 percent of hospitalized patients with CAP do not respond to initial antibiotic therapy within 72 hours. These patients have a much higher mortality rate than those who respond. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'The nonresponding patient'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Among patients with CAP who require hospitalization, prior pneumococcal and influenza vaccination have been associated with better outcomes. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Vaccination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      CAP has been associated with acute cardiac events. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Association with acute cardiac events'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/1\">",
"      File TM. Community-acquired pneumonia. Lancet 2003; 362:1991.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/2\">",
"      Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44 Suppl 2:S27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/3\">",
"      Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 1996; 275:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/4\">",
"      Fine MJ, Stone RA, Singer DE, et al. Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study. Arch Intern Med 1999; 159:970.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/5\">",
"      Ruhnke GW, Coca-Perraillon M, Kitch BT, Cutler DM. Marked reduction in 30-day mortality among elderly patients with community-acquired pneumonia. Am J Med 2011; 124:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/6\">",
"      Lindenauer PK, Lagu T, Shieh MS, et al. Association of diagnostic coding with trends in hospitalizations and mortality of patients with pneumonia, 2003-2009. JAMA 2012; 307:1405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/7\">",
"      Sarrazin MS, Rosenthal GE. Finding pure and simple truths with administrative data. JAMA 2012; 307:1433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/8\">",
"      Metersky ML, Waterer G, Nsa W, Bratzler DW. Predictors of in-hospital vs postdischarge mortality in pneumonia. Chest 2012; 142:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/9\">",
"      El Moussaoui R, Opmeer BC, de Borgie CA, et al. Long-term symptom recovery and health-related quality of life in patients with mild-to-moderate-severe community-acquired pneumonia. Chest 2006; 130:1165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/10\">",
"      Kaplan V, Clermont G, Griffin MF, et al. Pneumonia: still the old man's friend? Arch Intern Med 2003; 163:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/11\">",
"      Bordon J, Wiemken T, Peyrani P, et al. Decrease in long-term survival for hospitalized patients with community-acquired pneumonia. Chest 2010; 138:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/12\">",
"      Sligl WI, Eurich DT, Marrie TJ, Majumdar SR. Only severely limited, premorbid functional status is associated with short- and long-term mortality in patients with pneumonia who are critically ill: a prospective observational study. Chest 2011; 139:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/13\">",
"      Marrie TJ, Lau CY, Wheeler SL, et al. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA 2000; 283:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/14\">",
"      Men&eacute;ndez R, Torres A, Zalaca&iacute;n R, et al. Guidelines for the treatment of community-acquired pneumonia: predictors of adherence and outcome. Am J Respir Crit Care Med 2005; 172:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/15\">",
"      Men&eacute;ndez R, Ferrando D, Vall&eacute;s JM, Vallterra J. Influence of deviation from guidelines on the outcome of community-acquired pneumonia. Chest 2002; 122:612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/16\">",
"      Dean NC, Bateman KA, Donnelly SM, et al. Improved clinical outcomes with utilization of a community-acquired pneumonia guideline. Chest 2006; 130:794.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/17\">",
"      Bod&iacute; M, Rodr&iacute;guez A, Sol&eacute;-Viol&aacute;n J, et al. Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival. Clin Infect Dis 2005; 41:1709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/18\">",
"      Mortensen EM, Restrepo M, Anzueto A, Pugh J. Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia. Am J Med 2004; 117:726.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/19\">",
"      Mortensen EM, Restrepo MI, Anzueto A, Pugh JA. Antibiotic therapy and 48-hour mortality for patients with pneumonia. Am J Med 2006; 119:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/20\">",
"      Frei CR, Restrepo MI, Mortensen EM, Burgess DS. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia. Am J Med 2006; 119:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/21\">",
"      Dambrava PG, Torres A, Vall&egrave;s X, et al. Adherence to guidelines' empirical antibiotic recommendations and community-acquired pneumonia outcome. Eur Respir J 2008; 32:892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/22\">",
"      Blasi F, Iori I, Bulfoni A, et al. Can CAP guideline adherence improve patient outcome in internal medicine departments? Eur Respir J 2008; 32:902.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/23\">",
"      Shorr AF, Bodi M, Rodriguez A, et al. Impact of antibiotic guideline compliance on duration of mechanical ventilation in critically ill patients with community-acquired pneumonia. Chest 2006; 130:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/24\">",
"      McCabe C, Kirchner C, Zhang H, et al. Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules. Arch Intern Med 2009; 169:1525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/25\">",
"      Mart&iacute;nez R, Reyes S, Lorenzo MJ, Men&eacute;ndez R. Impact of guidelines on outcome: the evidence. Semin Respir Crit Care Med 2009; 30:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/26\">",
"      Marrie TJ. Community-acquired pneumonia. Clin Infect Dis 1994; 18:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/27\">",
"      Guidelines for the management of community-acquired pneumonia in adults admitted to hospital. The British Thoracic Society. Br J Hosp Med 1993; 49:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/28\">",
"      Farr BM, Sloman AJ, Fisch MJ. Predicting death in patients hospitalized for community-acquired pneumonia. Ann Intern Med 1991; 115:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/29\">",
"      Fine MJ, Singer DE, Hanusa BH, et al. Validation of a pneumonia prognostic index using the MedisGroups Comparative Hospital Database. Am J Med 1993; 94:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/30\">",
"      Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med 1995; 333:1618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/31\">",
"      Mortensen EM, Coley CM, Singer DE, et al. Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med 2002; 162:1059.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/32\">",
"      Marrie TJ, Wu L. Factors influencing in-hospital mortality in community-acquired pneumonia: a prospective study of patients not initially admitted to the ICU. Chest 2005; 127:1260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/33\">",
"      Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/34\">",
"      Aujesky D, Auble TE, Yealy DM, et al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med 2005; 118:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/35\">",
"      Chalmers JD, Taylor JK, Mandal P, et al. Validation of the Infectious Diseases Society of America/American Thoratic Society minor criteria for intensive care unit admission in community-acquired pneumonia patients without major criteria or contraindications to intensive care unit care. Clin Infect Dis 2011; 53:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/36\">",
"      Kothe H, Bauer T, Marre R, et al. Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment. Eur Respir J 2008; 32:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/37\">",
"      Garcia-Vidal C, Fern&aacute;ndez-Sab&eacute; N, Carratal&agrave; J, et al. Early mortality in patients with community-acquired pneumonia: causes and risk factors. Eur Respir J 2008; 32:733.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/38\">",
"      Men&eacute;ndez R, Torres A, Zalaca&iacute;n R, et al. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax 2004; 59:960.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/39\">",
"      Mirsaeidi M, Peyrani P, Aliberti S, et al. Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia. Chest 2010; 137:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/40\">",
"      Restrepo MI, Mortensen EM, Rello J, et al. Late admission to the ICU in patients with community-acquired pneumonia is associated with higher mortality. Chest 2010; 137:552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/41\">",
"      Lepper PM, Ott S, N&uuml;esch E, et al. Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort study. BMJ 2012; 344:e3397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/42\">",
"      Remmelts HH, van de Garde EM, Meijvis SC, et al. Addition of vitamin D status to prognostic scores improves the prediction of outcome in community-acquired pneumonia. Clin Infect Dis 2012; 55:1488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/43\">",
"      Rello J, Rodriguez A, Lisboa T, et al. PIRO score for community-acquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia. Crit Care Med 2009; 37:456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/44\">",
"      Ros&oacute;n B, Carratal&agrave; J, Fern&aacute;ndez-Sab&eacute; N, et al. Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia. Arch Intern Med 2004; 164:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/45\">",
"      Johnstone J, Marrie TJ, Eurich DT, Majumdar SR. Effect of pneumococcal vaccination in hospitalized adults with community-acquired pneumonia. Arch Intern Med 2007; 167:1938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/46\">",
"      Fisman DN, Abrutyn E, Spaude KA, et al. Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia. Clin Infect Dis 2006; 42:1093.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/47\">",
"      Vila-Corcoles A, Ochoa-Gondar O, Guzm&aacute;n JA, et al. Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older. BMC Infect Dis 2010; 10:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/48\">",
"      Maruyama T, Taguchi O, Niederman MS, et al. Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial. BMJ 2010; 340:c1004.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/49\">",
"      Nichol KL, Nordin J, Mullooly J, et al. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003; 348:1322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/50\">",
"      Herzog NS, Bratzler DW, Houck PM, et al. Effects of previous influenza vaccination on subsequent readmission and mortality in elderly patients hospitalized with pneumonia. Am J Med 2003; 115:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/51\">",
"      Musher DM, Rueda AM, Kaka AS, Mapara SM. The association between pneumococcal pneumonia and acute cardiac events. Clin Infect Dis 2007; 45:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/52\">",
"      Ramirez J, Aliberti S, Mirsaeidi M, et al. Acute myocardial infarction in hospitalized patients with community-acquired pneumonia. Clin Infect Dis 2008; 47:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/48/1801/abstract/53\">",
"      Corrales-Medina VF, Musher DM, Shachkina S, Chirinos JA. Acute pneumonia and the cardiovascular system. Lancet 2013; 381:496.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7016 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-58.240.98.179-9F9DC17642-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_48_1801=[""].join("\n");
var outline_f1_48_1801=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MORTALITY AND SYMPTOM RESOLUTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H340908692\">",
"      In-hospital and postdischarge mortality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H371246805\">",
"      Long-term outcomes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Impact of guidelines",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PREDICTORS OF MORTALITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CURB-65 score",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Pneumonia severity index",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17910454\">",
"      IDSA/ATS minor criteria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Additional factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      ICU patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Etiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      The nonresponding patient",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Vaccination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Pneumococcus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Influenza",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      ASSOCIATION WITH ACUTE CARDIAC EVENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/7016\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/7016|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?13/7/13435\" title=\"table 1\">",
"      PSI and mortality",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?40/62/41952?source=related_link\" title=\"calculator 1\">",
"      Calculator: CURB-65 pneumonia severity score",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?43/42/44705?source=related_link\" title=\"calculator 2\">",
"      Calculator: Community-acquired pneumonia severity index (PSI) for adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/33/29210?source=related_link\">",
"      Antibiotic studies for the treatment of community-acquired pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/18/31017?source=related_link\">",
"      Aspiration pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/36/38473?source=related_link\">",
"      Community-acquired pneumonia in adults: Risk stratification and the decision to admit",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/26/26026?source=related_link\">",
"      Diagnostic approach to community-acquired pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/49/31514?source=related_link\">",
"      Epidemiology, pathogenesis, and microbiology of community-acquired pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/24/23945?source=related_link\">",
"      Nonresolving pneumonia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?12/29/12754?source=related_link\">",
"      Patient information: Community-acquired pneumonia in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?29/38/30308?source=related_link\">",
"      Patient information: Pneumonia in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/56/27527?source=related_link\">",
"      Predictive scoring systems in the intensive care unit",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/49/21273?source=related_link\">",
"      Pulmonary infections in immunocompromised patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/7/13433?source=related_link\">",
"      Risk factors and prevention of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/8/37002?source=related_link\">",
"      Seasonal influenza vaccination in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/63/10230?source=related_link\">",
"      Statins: Possible noncardiovascular benefits",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/24/24969?source=related_link\">",
"      Treatment of community-acquired pneumonia in adults in the outpatient setting",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/1/40986?source=related_link\">",
"      Treatment of community-acquired pneumonia in adults who require hospitalization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/29/31193?source=related_link\">",
"      Vitamin D and extraskeletal health",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_48_1802="Basic case 15";
var content_f1_48_1802=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F65389&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F65389&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1130px;\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Basic case 15",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 277px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal rhythm strip",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 165px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal rhythm strip in lead II. The PR interval is 0.15 sec and the QRS duration is 0.08 sec. Both the P and T waves are upright.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Morton F Arnsdorf, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_48_1802=[""].join("\n");
var outline_f1_48_1802=null;
var title_f1_48_1803="Thoracic defects causing hydrop";
var content_f1_48_1803=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F66844&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F66844&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Thoracic abnormalities associated with hydrops fetalis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td>",
"       <p>",
"        Congenital pulmonary airway malformation (CPAM)",
"       </p>",
"       <p>",
"        (formerly known as congenital cystic adenomatoid malformation, CCAM)",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Diaphragmatic hernia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pulmonary sequestration",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Chylothorax",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Lymphangiectasia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Neoplasms",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Bronchogenic cyst",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_48_1803=[""].join("\n");
var outline_f1_48_1803=null;
var title_f1_48_1804="Confusion assessment method";
var content_f1_48_1804=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F69489&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F69489&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Confusion assessment method (CAM) for the diagnosis of delirium*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Feature",
"      </td>",
"      <td class=\"subtitle1\">",
"       Assessment",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       1. Acute onset and fluctuating course",
"      </td>",
"      <td>",
"       <p>",
"        Usually obtained from a family member or nurse and shown by positive responses to the following questions:",
"       </p>",
"       <p>",
"        \"Is there evidence of an acute change in mental status from the patient's baseline?\";",
"       </p>",
"       <p>",
"        \"Did the abnormal behavior fluctuate during the day, that is, tend to come and go, or increase and decrease in severity?\"",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       2. Inattention",
"      </td>",
"      <td>",
"       <p>",
"        Shown by a positive response to the following:",
"       </p>",
"       <p>",
"        \"Did the patient have difficulty focusing attention, for example, being easily distractible or having difficulty keeping track of what was being said?\"",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       3. Disorganized thinking",
"      </td>",
"      <td>",
"       <p>",
"        Shown by a positive response to the following:",
"       </p>",
"       <p>",
"        \"Was the patient's thinking disorganized or incoherent, such as rambling or irrelevant conversation, unclear or illogical flow of ideas, or unpredictable switching from subject to subject?\"",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"7\">",
"       4. Altered level of consciousness",
"      </td>",
"      <td>",
"       Shown by any answer other than \"alert\" to the following:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       \"Overall, how would you rate this patient's level ofconsciousness?\"",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Normal = alert",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Hyperalert = vigilant",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Drowsy, easily aroused = lethargic",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Difficult to arouse = stupor",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Unarousable = coma",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    *The diagnosis of delirium requires the presence of features 1 AND 2 plus either 3 OR 4.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_48_1804=[""].join("\n");
var outline_f1_48_1804=null;
var title_f1_48_1805="MMR and VZV in immune globulin or blood product recipients";
var content_f1_48_1805=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F72640&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=13\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F72640&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=13\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Suggested interval between immune globulin (IG) or blood product and measles (MMR, MMRV) or VZV vaccine",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Product",
"       </td>",
"       <td class=\"subtitle1\">",
"        Interval (months)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Intramuscular immune globulin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hepatitis A prophylaxis (IG)",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\" colspan=\"2\">",
"        Measles prophylaxis (IG)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Standard",
"       </td>",
"       <td class=\"sublist_other\">",
"        5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Immunocompromised host",
"       </td>",
"       <td class=\"sublist_other\">",
"        6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Tetanus immune globulin",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hepatitis B immune globulin",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Rabies immune globulin",
"       </td>",
"       <td>",
"        4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Varicella prophylaxis (as VariZIG)",
"       </td>",
"       <td>",
"        5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        RSV prophylaxis (Palivizumab [Synagis])",
"       </td>",
"       <td>",
"        None",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Intravenous immune globulin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\" colspan=\"2\">",
"        Replacement therapy (IVIG)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        300-400 mg/kg",
"       </td>",
"       <td class=\"sublist_other\">",
"        8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\" colspan=\"2\">",
"        For ITP (IVIG)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        400 mg/kg",
"       </td>",
"       <td class=\"sublist_other\">",
"        8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        1000 mg/kg",
"       </td>",
"       <td class=\"sublist_other\">",
"        10",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\" colspan=\"2\">",
"        For ITP or Kawasaki syndrome (IVIG)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        1600-2000 mg/kg",
"       </td>",
"       <td class=\"sublist_other\">",
"        11",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cytomegalovirus immune globulin",
"       </td>",
"       <td>",
"        6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Blood products",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Washed RBCs",
"       </td>",
"       <td>",
"        0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        RBCs, adenine-saline added",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Packed RBCs",
"       </td>",
"       <td>",
"        5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Whole blood",
"       </td>",
"       <td>",
"        6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Plasma or platelet products",
"       </td>",
"       <td>",
"        7",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     MMR: measles, mumps, rubella vaccine; MMRV: measles, mumps, rubella, varicella vaccine; VZV: varicella zoster virus vaccine; RSV: repiratory syncytial virus; ITP: idiopathic thrombocytopenic purpura; RBCs: red blood cells.",
"    </div>",
"    <div class=\"reference\">",
"     Data from: American Academy of Pediatrics. Active immunization of people who recently received immune globulin and other blood products. Red Book: 2012 Report of the Committee on Infectious Diseases, 29th ed, Pickering LK (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2012.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_48_1805=[""].join("\n");
var outline_f1_48_1805=null;
var title_f1_48_1806="Direct global costs burns";
var content_f1_48_1806=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F82340&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F82340&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Estimated direct costs of fires in 2006 as a percentage of the GDP",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"6\" width=\"16%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Country",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Currency",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"3\">",
"        Direct losses",
"       </td>",
"       <td class=\"subtitle1\">",
"        Cost as percentage of GDP",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        2007",
"       </td>",
"       <td class=\"subtitle2\">",
"        2008",
"       </td>",
"       <td class=\"subtitle2\">",
"        2009",
"       </td>",
"       <td class=\"subtitle2\">",
"        2007-2009",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Singapore",
"       </td>",
"       <td class=\"centered\">",
"        $S",
"       </td>",
"       <td class=\"centered\">",
"        110",
"       </td>",
"       <td class=\"centered\">",
"        110",
"       </td>",
"       <td class=\"centered\">",
"        115",
"       </td>",
"       <td class=\"centered\">",
"        0.04",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Slovenia",
"       </td>",
"       <td class=\"centered\">",
"        SIT",
"       </td>",
"       <td class=\"centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        0.07 (2002-2004)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Australia*",
"       </td>",
"       <td class=\"centered\">",
"        $AUS",
"       </td>",
"       <td class=\"centered\">",
"        905",
"       </td>",
"       <td class=\"centered\">",
"        1000",
"       </td>",
"       <td class=\"centered\">",
"        945",
"       </td>",
"       <td class=\"centered\">",
"        0.08",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Czech Republic",
"       </td>",
"       <td class=\"centered\">",
"        K������",
"       </td>",
"       <td class=\"centered\">",
"        2450",
"       </td>",
"       <td class=\"centered\">",
"        3700",
"       </td>",
"       <td class=\"centered\">",
"        2450",
"       </td>",
"       <td class=\"centered\">",
"        0.08",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Spain",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td class=\"centered\">",
"        &euro;",
"       </td>",
"       <td class=\"centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        910",
"       </td>",
"       <td class=\"centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        0.08 (2008)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Poland",
"       </td>",
"       <td class=\"centered\">",
"        zl",
"       </td>",
"       <td class=\"centered\">",
"        900",
"       </td>",
"       <td class=\"centered\">",
"        1450",
"       </td>",
"       <td class=\"centered\">",
"        1150",
"       </td>",
"       <td class=\"centered\">",
"        0.09",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        United States",
"       </td>",
"       <td class=\"centered\">",
"        $US",
"       </td>",
"       <td class=\"centered\">",
"        16,500",
"       </td>",
"       <td class=\"centered\">",
"        17,500",
"       </td>",
"       <td class=\"centered\">",
"        14,000",
"       </td>",
"       <td class=\"centered\">",
"        0.11",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Japan",
"       </td>",
"       <td class=\"centered\">",
"        &yen;",
"       </td>",
"       <td class=\"centered\">",
"        600",
"       </td>",
"       <td class=\"centered\">",
"        615",
"       </td>",
"       <td class=\"centered\">",
"        605",
"       </td>",
"       <td class=\"centered\">",
"        0.12",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        New Zealand",
"       </td>",
"       <td class=\"centered\">",
"        $NZ",
"       </td>",
"       <td class=\"centered\">",
"        180",
"       </td>",
"       <td class=\"centered\">",
"        240",
"       </td>",
"       <td class=\"centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        0.12 (2007-2008)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Germany",
"       </td>",
"       <td class=\"centered\">",
"        &euro;",
"       </td>",
"       <td class=\"centered\">",
"        2950",
"       </td>",
"       <td class=\"centered\">",
"        2850",
"       </td>",
"       <td class=\"centered\">",
"        3050",
"       </td>",
"       <td class=\"centered\">",
"        0.12",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        United Kingdom",
"       </td>",
"       <td class=\"centered\">",
"        &pound;",
"       </td>",
"       <td class=\"centered\">",
"        1700",
"       </td>",
"       <td class=\"centered\">",
"        1950",
"       </td>",
"       <td class=\"centered\">",
"        1800",
"       </td>",
"       <td class=\"centered\">",
"        0.13",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Finland",
"       </td>",
"       <td class=\"centered\">",
"        &euro;",
"       </td>",
"       <td class=\"centered\">",
"        315",
"       </td>",
"       <td class=\"centered\">",
"        305",
"       </td>",
"       <td class=\"centered\">",
"        295",
"       </td>",
"       <td class=\"centered\">",
"        0.17",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Netherlands",
"       </td>",
"       <td class=\"centered\">",
"        &euro;",
"       </td>",
"       <td class=\"centered\">",
"        900",
"       </td>",
"       <td class=\"centered\">",
"        1050",
"       </td>",
"       <td class=\"centered\">",
"        925",
"       </td>",
"       <td class=\"centered\">",
"        0.17",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sweden",
"       </td>",
"       <td class=\"centered\">",
"        kr",
"       </td>",
"       <td class=\"centered\">",
"        5400",
"       </td>",
"       <td class=\"centered\">",
"        5950",
"       </td>",
"       <td class=\"centered\">",
"        5550",
"       </td>",
"       <td class=\"centered\">",
"        0.18",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Denmark",
"       </td>",
"       <td class=\"centered\">",
"        kr",
"       </td>",
"       <td class=\"centered\">",
"        4050",
"       </td>",
"       <td class=\"centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        0.20 (2005-2007)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        France",
"       </td>",
"       <td class=\"centered\">",
"        &euro;",
"       </td>",
"       <td class=\"centered\">",
"        3400",
"       </td>",
"       <td class=\"centered\">",
"        4550",
"       </td>",
"       <td class=\"centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        0.20",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Italy",
"       </td>",
"       <td class=\"centered\">",
"        &euro;",
"       </td>",
"       <td class=\"centered\">",
"        2500",
"       </td>",
"       <td class=\"centered\">",
"        3150",
"       </td>",
"       <td class=\"centered\">",
"        3750",
"       </td>",
"       <td class=\"centered\">",
"        0.20",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Norway",
"       </td>",
"       <td class=\"centered\">",
"        kr",
"       </td>",
"       <td class=\"centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        0.22 (2003-2005)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Note: Fire losses include explosion losses following fire, but exclude explosion losses where no fire occurs (for example, some acts of terrorism).",
"    <div class=\"footnotes\">",
"     GDP: gross domestic product.",
"     <br/>",
"     * Australian data is calculated from figures provided in the Report on Government Services 2012 and may be influenced by specific methodological features of that publication.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     Spanish figures rely upon internal WFSC estimates derived from Spanish insurance data and have not had adjustments applied; consequently, this data should be regarded with caution.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: World Fire Statistics Newsletter 28. Information Bulletin of the World Fire Statistics Centre. Geneva Association Information Newsletter, Geneva, Switzerland, Oct&nbsp;2012. Copyright &copy; 2013 The Geneva Association.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_48_1806=[""].join("\n");
var outline_f1_48_1806=null;
var title_f1_48_1807="Contents: Pediatric procedures";
var content_f1_48_1807=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?1/34/1568\">",
"       Family Medicine and General Practice",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Pediatric procedures",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Pediatric procedures",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Airway",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/22/29030\">",
"           Basic airway management in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/26/39337\">",
"           Devices for difficult endotracheal intubation in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/61/17367\">",
"           Emergency airway management in children: Unique pediatric considerations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/45/37593\">",
"           Emergency rescue devices for difficult pediatric airway management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/48/29450\">",
"           Emergent endotracheal intubation in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/3/16441\">",
"           Needle cricothyroidotomy with percutaneous transtracheal ventilation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/29/24026\">",
"           Rapid sequence intubation (RSI) in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Anesthesia and sedation",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/9/23703\">",
"           Digital nerve block",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/57/33689\">",
"           Infiltration of local anesthetics",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/29/31194\">",
"           Pharmacologic agents for pediatric procedural sedation outside of the operating room",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/47/29432\">",
"           Preparation for pediatric procedural sedation outside of the operating room",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/23/43384\">",
"           Procedural sedation in children outside of the operating room",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/3/25658\">",
"           Selection of medications for pediatric procedural sedation outside of the operating room",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/50/43817\">",
"           Topical anesthetics in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Cardiopulmonary life support",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/17/28948\">",
"           Assessment of perfusion in pediatric resuscitation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/43/7864\">",
"           Basic life support in infants and children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/49/21272\">",
"           Defibrillation and cardioversion in children (including automated external defibrillation)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/51/40761\">",
"           Intraosseous infusion",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/55/8057\">",
"           Vascular (venous) access for pediatric resuscitation and other pediatric emergencies",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Cardiovascular",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/61/2009\">",
"           Arterial puncture and cannulation in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/47/3833\">",
"           Principles of ultrasound-guided venous access",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/55/8057\">",
"           Vascular (venous) access for pediatric resuscitation and other pediatric emergencies",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Ear nose and throat",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/53/28504\">",
"           Diagnosis and management of foreign bodies of the outer ear",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/21/17752\">",
"           Diagnosis and management of intranasal foreign bodies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/58/26536\">",
"           Management of epistaxis in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Gastroenterology",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/3/21561\">",
"           Overview of inguinal hernia in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Genitourinary",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/25/30100\">",
"           Management of zipper injuries",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/48/33543\">",
"           Paraphimosis reduction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/56/42886\">",
"           Urine collection techniques in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Minor emergency procedures",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/63/6137\">",
"           Assessment and management of auricle (ear) lacerations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/53/12122\">",
"           Assessment and management of facial lacerations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/51/18232\">",
"           Assessment and management of intra-oral lacerations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/29/23000\">",
"           Assessment and management of lip lacerations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/9/30872\">",
"           Assessment and management of scalp lacerations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/22/33124\">",
"           Closure of minor skin wounds with staples",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/7/18553\">",
"           Closure of skin wounds with sutures",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/53/16216\">",
"           Digit dislocation reduction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/47/24309\">",
"           Evaluation and repair of tongue lacerations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/42/38564\">",
"           Fish-hook removal techniques",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/47/13044\">",
"           Hair entrapment removal techniques",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/23/4472\">",
"           Management of fingertip injuries",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/25/30100\">",
"           Management of zipper injuries",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/51/32567\">",
"           Minor wound preparation and irrigation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/40/38532\">",
"           Radial head subluxation (nursemaid's elbow)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/46/26340\">",
"           Reduction of temporomandibular joint (TMJ) dislocation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/49/8981\">",
"           Ring removal techniques",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/8/9351\">",
"           Subungual hematoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/32/41478\">",
"           Superficial wound repair with tissue adhesives",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/46/5865\">",
"           Technique of incision and drainage for skin abscess",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Musculoskeletal",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/40/31368\">",
"           Closed reduction and casting of distal forearm fractures in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/9/38038\">",
"           Knee (tibiofemoral) dislocation and reduction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/0/24581\">",
"           Patellar dislocations in children and adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/44/6854\">",
"           Pediatric cervical spine immobilization",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/40/38532\">",
"           Radial head subluxation (nursemaid's elbow)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/46/26340\">",
"           Reduction of temporomandibular joint (TMJ) dislocation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/54/15208\">",
"           Splinting of musculoskeletal injuries",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/8/9351\">",
"           Subungual hematoma",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Neurology",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/1/25625\">",
"           Lumbar puncture: Indications, contraindications, technique, and complications in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/44/6854\">",
"           Pediatric cervical spine immobilization",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Ophthalmology",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/28/44486\">",
"           Slit lamp examination",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pulmonary",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/61/2009\">",
"           Arterial puncture and cannulation in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/12/1226\">",
"           Placement and management of thoracostomy tubes",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Trauma life support",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/44/6854\">",
"           Pediatric cervical spine immobilization",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/12/1226\">",
"           Placement and management of thoracostomy tubes",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-46C78F51C6-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f1_48_1807=[""].join("\n");
var outline_f1_48_1807=null;
